Stromal	B-protein
cell-derived	I-protein
factor	I-protein
1	I-protein
alpha	I-protein
-induced	O
chemotaxis	O
in	O
T	B-cell_type
cells	I-cell_type
is	O
mediated	O
by	O
nitric	O
oxide	O
signaling	O
pathways	O
.	O

Stromal	B-protein
cell-derived	I-protein
factor	I-protein
1	I-protein
alpha	I-protein
(	O
SDF1	B-protein
alpha	I-protein
)	O
and	O
its	O
cognate	O
chemokine	B-protein
receptor	I-protein
CXCR4	I-protein
act	O
as	O
potent	O
chemoattractants	O
and	O
regulate	O
trafficking	O
and	O
homing	O
of	O
hematopoietic	B-cell_type
progenitor	I-cell_type
cells	I-cell_type
and	O
lymphocytes	B-cell_type
.	O

However	O
,	O
the	O
molecular	O
mechanisms	O
regulating	O
SDF1	B-protein
alpha	I-protein
-driven	O
cell	O
migration	O
are	O
not	O
well	O
defined	O
.	O

In	O
this	O
study	O
,	O
we	O
have	O
explored	O
the	O
roles	O
of	O
the	O
second	O
messenger	O
NO	O
and	O
the	O
transcription	B-protein
factor	I-protein
NF-kappa	I-protein
B	I-protein
in	O
SDF1	B-protein
alpha	I-protein
-induced	O
T	O
cell	O
migration	O
.	O

SDF1	B-protein
alpha	I-protein
treatment	O
of	O
Jurkat	B-cell_line
T	I-cell_line
cells	I-cell_line
increased	O
the	O
activity	O
of	O
NO	B-protein
synthase	I-protein
,	O
which	O
catalyzes	O
the	O
generation	O
of	O
NO	O
.	O

We	O
observed	O
that	O
pretreatment	O
of	O
Jurkat	B-cell_line
cells	I-cell_line
or	O
activated	O
PBLs	B-cell_type
with	O
several	O
NO	O
donors	O
significantly	O
enhanced	O
the	O
SDF1	B-protein
alpha	I-protein
-induced	O
migration	O
,	O
whereas	O
various	O
inhibitors	O
of	O
NO	B-protein
synthase	I-protein
markedly	O
abrogated	O
the	O
chemotactic	O
response	O
in	O
a	O
concentration-dependent	O
manner	O
.	O

Furthermore	O
,	O
we	O
observed	O
that	O
inhibitors	O
of	O
the	O
transcription	B-protein
factor	I-protein
NF-kappa	I-protein
B	I-protein
,	O
which	O
is	O
linked	O
to	O
NO	O
signaling	O
pathways	O
,	O
also	O
significantly	O
blocked	O
the	O
SDF1	B-protein
alpha	I-protein
-induced	O
chemotactic	O
response	O
.	O

However	O
,	O
these	O
compounds	O
did	O
not	O
have	O
a	O
significant	O
effect	O
on	O
SDF1	B-protein
alpha	I-protein
-induced	O
mitogen-activated	O
protein	O
kinase	O
activity	O
.	O

In	O
addition	O
,	O
the	O
MAP/Erk	O
kinase	O
kinase	O
inhibitor	O
PD98059	O
did	O
not	O
abrogate	O
SDF1	B-protein
alpha	I-protein
-induced	O
chemotaxis	O
.	O

AKT	B-protein
,	O
which	O
has	O
been	O
shown	O
to	O
mediate	O
NO	O
production	O
,	O
was	O
also	O
phosphorylated	O
upon	O
SDF1	B-protein
alpha	I-protein
stimulation	O
.	O

These	O
studies	O
suggest	O
that	O
NO-related	O
signaling	O
pathways	O
may	O
mediate	O
SDF1	B-protein
alpha	I-protein
-induced	O
chemotaxis	O
,	O
but	O
not	O
mitogen-activated	B-protein
protein	I-protein
kinase	I-protein
activation	O
.	O

'_9	NULL
Analytes	NULL
=	NULL
Comprehensive	NULL
Analysis	NULL
n	NULL
MICFOVUG	NULL
Wiki	NULL
-	NULL
Ba	NULL
,	NULL
Bb	NULL
,	NULL
C3a	NULL
,	NULL
C4a	NULL
,	NULL
C4d	NULL
,	NULL
C5a	NULL
,	NULL
s	NULL
SCS5b-9	NULL
,	NULL
Factor	NULL
H	NULL
,	NULL
Factor	NULL
|	NULL
QUIpEL	NULL
MULTIPLEX	NULL
I	NULL
ill	NULL
``	NULL
``	NULL
A	NULL
SE	NULL
ANTS	NULL
ty	NULL
ay	NULL
Ka	NULL
meJournal	NULL
o	NULL
Stromal	NULL
Cell-Derived	NULL
Factor	NULL
1	NULL
(	NULL
-Induced	NULL
5-	NULL
%	NULL
-	NULL
:	NULL
'Immun010	NULL
gy	NULL
Chemotaxis	NULL
in	NULL
T	NULL
Cells	NULL
Is	NULL
Mediated	NULL
by	NULL
Nitric	NULL
Oxide	NULL
Signaling	NULL
Pathways	NULL
Rama	NULL
P.	NULL
Cherla	NULL
and	NULL
Ramesh	NULL
K.	NULL
Ganju	NULL
J	NULL
Immunol	NULL
2001	NULL
;	NULL
166:3067-3074	NULL
;	NULL
;	NULL
doi	NULL
:	NULL
10.4049/jimmunol.166.5.3067	NULL
http	NULL
:	NULL
//www	NULL
.jimmunol.org/content/166/5/3067	NULL
\ge	NULL
?	NULL

u	NULL
This	NULL
information	NULL
is	NULL
current	NULL
as	NULL
of	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

References	NULL
_	NULL
This	NULL
article	NULL
cites	NULL
83	NULL
articles	NULL
,	NULL
41	NULL
of	NULL
which	NULL
you	NULL
can	NULL
access	NULL
for	NULL
free	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www	NULL
.jimmunol.org/content/166/5/3067	NULL
full	NULL
#	NULL
ref-list-1	NULL
Why	NULL
The	NULL
JT	NULL
?	NULL

Submit	NULL
online	NULL
.	NULL

«	NULL
Rapid	NULL
Reviews	NULL
!	NULL

30	NULL
days*	NULL
from	NULL
submission	NULL
to	NULL
initial	NULL
decision	NULL
*	NULL
No	NULL
Triage	NULL
!	NULL

Every	NULL
submission	NULL
reviewed	NULL
by	NULL
practicing	NULL
scientists	NULL
*	NULL
Fast	NULL
Publication	NULL
!	NULL

4	NULL
weeks	NULL
from	NULL
acceptance	NULL
to	NULL
publication	NULL
*average	NULL
Subscription	NULL
_-	NULL
Information	NULL
about	NULL
subscribing	NULL
to	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
is	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//jimmunol.org/subscription	NULL
Permissions	NULL
_	NULL
Submit	NULL
copyright	NULL
permission	NULL
requests	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.aai.org/About/Publications/Jl/copyright.html	NULL
Email	NULL
Alerts	NULL
_	NULL
Receive	NULL
free	NULL
email-alerts	NULL
when	NULL
new	NULL
articles	NULL
cite	NULL
this	NULL
article	NULL
.	NULL

Sign	NULL
up	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//jimmunol.org/alerts	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
is	NULL
published	NULL
twice	NULL
each	NULL
month	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
,	NULL
Inc.	NULL
,	NULL
1451	NULL
Rockville	NULL
Pike	NULL
,	NULL
Suite	NULL
650	NULL
,	NULL
Rockville	NULL
,	NULL
MD	NULL
20852	NULL
Copyright	NULL
©	NULL
2001	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
All	NULL
rights	NULL
reserved	NULL
.	NULL

Print	NULL
ISSN	NULL
:	NULL
0022-1767	NULL
Online	NULL
ISSN	NULL
:	NULL
1550-6606	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
Stromal	NULL
Cell-Derived	NULL
Factor	NULL
1a-Induced	NULL
Chemotaxis	NULL
in	NULL
T	NULL
Cells	NULL
Is	NULL
Mediated	NULL
by	NULL
Nitric	NULL
Oxide	NULL
Signaling	NULL
Pathways	NULL
Rama	NULL
P.	NULL
Cherla	NULL
and	NULL
Ramesh	NULL
K.	NULL
Ganju*	NULL
Stromal	NULL
cell-derived	NULL
factor	NULL
1	NULL
«	NULL
(	NULL
SDF1a	NULL
)	NULL
and	NULL
its	NULL
cognate	NULL
chemokine	NULL
receptor	NULL
CXCR4	NULL
act	NULL
as	NULL
potent	NULL
chemoattractants	NULL
and	NULL
regulate	NULL
trafficking	NULL
and	NULL
homing	NULL
of	NULL
hematopoietic	NULL
progenitor	NULL
cells	NULL
and	NULL
lymphocytes	NULL
.	NULL

However	NULL
,	NULL
the	NULL
molecular	NULL
mechanisms	NULL
regulating	NULL
SDF1a-driven	NULL
cell	NULL
migration	NULL
are	NULL
not	NULL
well	NULL
defined	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
have	NULL
explored	NULL
the	NULL
roles	NULL
of	NULL
the	NULL
second	NULL
messenger	NULL
NO	NULL
and	NULL
the	NULL
transcription	NULL
factor	NULL
NF-KB	NULL
in	NULL
SDF1la	NULL
&	NULL
-induced	NULL
T	NULL
cell	NULL
migration	NULL
.	NULL

SDF1la	NULL
treatment	NULL
of	NULL
Jurkat	NULL
T	NULL
cells	NULL
increased	NULL
the	NULL
activity	NULL
of	NULL
NO	NULL
synthase	NULL
,	NULL
which	NULL
catalyzes	NULL
the	NULL
generation	NULL
of	NULL
NO	NULL
.	NULL

We	NULL
observed	NULL
that	NULL
pretreatment	NULL
of	NULL
Jurkat	NULL
cells	NULL
or	NULL
activated	NULL
PBLs	NULL
with	NULL
several	NULL
NO	NULL
donors	NULL
significantly	NULL
enhanced	NULL
the	NULL
SDF1a	NULL
&	NULL
-induced	NULL
migration	NULL
,	NULL
whereas	NULL
various	NULL
inhibitors	NULL
of	NULL
NO	NULL
synthase	NULL
markedly	NULL
abrogated	NULL
the	NULL
chemotactic	NULL
response	NULL
in	NULL
a	NULL
concentration-dependent	NULL
manner	NULL
.	NULL

Furthermore	NULL
,	NULL
we	NULL
observed	NULL
that	NULL
inhibitors	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
NF-B	NULL
,	NULL
which	NULL
is	NULL
linked	NULL
to	NULL
NO	NULL
signaling	NULL
pathways	NULL
,	NULL
also	NULL
significantly	NULL
blocked	NULL
the	NULL
SDF1a	NULL
&	NULL
-induced	NULL
chemotactic	NULL
response	NULL
.	NULL

However	NULL
,	NULL
these	NULL
compounds	NULL
did	NULL
not	NULL
have	NULL
a	NULL
significant	NULL
effect	NULL
on	NULL
SDF1la	NULL
&	NULL
-induced	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
activity	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
MAP/Erk	NULL
kinase	NULL
kinase	NULL
inhibitor	NULL
PD98059	NULL
did	NULL
not	NULL
abrogate	NULL
SDF1a	NULL
&	NULL
-induced	NULL
chemotaxis	NULL
.	NULL

AKT	NULL
,	NULL
which	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
mediate	NULL
NO	NULL
production	NULL
,	NULL
was	NULL
also	NULL
phosphorylated	NULL
upon	NULL
SDF1	NULL
«	NULL
stimulation	NULL
.	NULL

These	NULL
studies	NULL
suggest	NULL
that	NULL
NO-related	NULL
signaling	NULL
pathways	NULL
may	NULL
mediate	NULL
SDF1a	NULL
&	NULL
-induced	NULL
chemotaxis	NULL
,	NULL
but	NULL
not	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
activation	NULL
.	NULL

-	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
,	NULL
2001	NULL
,	NULL
166	NULL
:	NULL
3067-3074.	NULL
hemokines	NULL
,	NULL
which	NULL
are	NULL
a	NULL
group	NULL
of	NULL
low	NULL
molecular	NULL
weight	NULL
proteins	NULL
,	NULL
mediate	NULL
several	NULL
cellular	NULL
functions	NULL
.	NULL

They	NULL
play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
hematopoiesis	NULL
,	NULL
leukocyte	NULL
maturation	NULL
,	NULL
angiogenesis	NULL
,	NULL
trafficking	NULL
,	NULL
and	NULL
homing	NULL
of	NULL
T	NULL
and	NULL
B	NULL
lymphocytes	NULL
and	NULL
in	NULL
the	NULL
development	NULL
of	NULL
lymphoid	NULL
tissue	NULL
(	NULL
1-6	NULL
)	NULL
.	NULL

Based	NULL
on	NULL
the	NULL
arrangement	NULL
of	NULL
their	NULL
first	NULL
two	NULL
of	NULL
four-conserved	NULL
cysteine	NULL
residues	NULL
,	NULL
the	NULL
chemokine	NULL
superfamily	NULL
has	NULL
been	NULL
divided	NULL
into	NULL
four	NULL
subfamilies	NULL
:	NULL
«	NULL
(	NULL
C-X-C	NULL
)	NULL
,	NULL
B	NULL
(	NULL
C-C	NULL
)	NULL
,	NULL
y	NULL
(	NULL
C	NULL
)	NULL
,	NULL
and	NULL
8	NULL
(	NULL
C-X-X-X-C	NULL
)	NULL
(	NULL
1	NULL
,	NULL
2	NULL
,	NULL
6	NULL
.	NULL

Stromal	NULL
cell-derived	NULL
factor	NULL
1	NULL
«	NULL
(	NULL
SDFia	NULL
)	NULL
is	NULL
a	NULL
member	NULL
of	NULL
the	NULL
CXC	NULL
or	NULL
e	NULL
«	NULL
-chemokine	NULL
subfamily	NULL
and	NULL
is	NULL
the	NULL
only	NULL
known	NULL
ligand	NULL
for	NULL
the	NULL
chemokine	NULL
receptor	NULL
CXCR4	NULL
(	NULL
7-10	NULL
)	NULL
.	NULL

SDFla	NULL
and	NULL
CXCR4	NULL
are	NULL
constitutively	NULL
expressed	NULL
in	NULL
a	NULL
large	NULL
number	NULL
of	NULL
tissues	NULL
(	NULL
10-14	NULL
)	NULL
.	NULL

CXCR4	NULL
plays	NULL
an	NULL
important	NULL
role	NULL
in	NULL
HIV	NULL
infection	NULL
and	NULL
pathogenesis	NULL
(	NULL
9	NULL
,	NULL
10	NULL
,	NULL
15	NULL
)	NULL
.	NULL

SDF1a	NULL
and	NULL
the	NULL
CXCR4	NULL
receptor	NULL
also	NULL
regulate	NULL
embryonic	NULL
development	NULL
(	NULL
16-19	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
knockout	NULL
mice	NULL
lacking	NULL
CXCR4	NULL
or	NULL
SDF1la	NULL
protein	NULL
are	NULL
embryologically	NULL
lethal	NULL
.	NULL

Knockout	NULL
studies	NULL
revealed	NULL
that	NULL
these	NULL
two	NULL
proteins	NULL
are	NULL
mandatory	NULL
for	NULL
various	NULL
developmental	NULL
processes	NULL
,	NULL
including	NULL
chemotaxis	NULL
or	NULL
homing	NULL
of	NULL
my	NULL
Divisions	NULL
of	NULL
Experimental	NULL
Medicine	NULL
and	NULL
Hematology/Oncology	NULL
,	NULL
Beth	NULL
Israel	NULL
Deaconess	NULL
Medical	NULL
Center	NULL
,	NULL
Harvard	NULL
Medical	NULL
School	NULL
,	NULL
Boston	NULL
,	NULL
MA	NULL
02115	NULL
Received	NULL
for	NULL
publication	NULL
August	NULL
1	NULL
,	NULL
2000	NULL
.	NULL

Accepted	NULL
for	NULL
publication	NULL
December	NULL
20	NULL
,	NULL
2000	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
adverfisement	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL
'	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
Grant	NULL
€CA76950	NULL
(	NULL
to	NULL
RK.G	NULL
)	NULL
.	NULL

?	NULL

Address	NULL
correspondence	NULL
and	NULL
reprint	NULL
requests	NULL
to	NULL
Dr.	NULL
Ramesh	NULL
K.	NULL
Ganju	NULL
,	NULL
Harvard	NULL
Institutes	NULL
of	NULL
Medicine-Beth	NULL
Israel	NULL
Deaconess	NULL
Medical	NULL
Center	NULL
,	NULL
4	NULL
Blackfan	NULL
Circle	NULL
,	NULL
Room	NULL
343	NULL
,	NULL
Boston	NULL
,	NULL
MA	NULL
02115	NULL
.	NULL

E-mail	NULL
address	NULL
:	NULL
rganju	NULL
@	NULL
caregroup.harvard.edu	NULL
3	NULL
Abbreviations	NULL
used	NULL
in	NULL
this	NULL
paper	NULL
:	NULL
SDF1a	NULL
@	NULL
,	NULL
stromal	NULL
cell-derived	NULL
factor	NULL
1	NULL
@	NULL
;	NULL
NOS	NULL
,	NULL
NO	NULL
synthase	NULL
;	NULL
RAFTK	NULL
,	NULL
related	NULL
adhesion	NULL
focal	NULL
tyrosine	NULL
kinase	NULL
;	NULL
SNAP	NULL
,	NULL
S-nitroso-M-acetyl	NULL
penicillamine	NULL
;	NULL
SNP	NULL
,	NULL
sodium	NULL
nitroprusside	NULL
;	NULL
PFC	NULL
,	NULL
4-phenyl-3-furoxancarbonitrite	NULL
;	NULL
TLCK	NULL
,	NULL
N-tosyl-lysine-chloromethylketone	NULL
;	NULL
L-NAME	NULL
,	NULL
NO-nitro-L-arginine	NULL
methyl	NULL
ester	NULL
;	NULL
L-NMMA	NULL
,	NULL
NO-monomethyl-L-arginine	NULL
monoacetate	NULL
;	NULL
TPCK	NULL
,	NULL
N*-tosyl-phenyl-alanine-chloromethylketone	NULL
;	NULL
MAP	NULL
,	NULL
mitogen-activated	NULL
protein	NULL
;	NULL
eNOS	NULL
,	NULL
endothelial	NULL
NOS	NULL
;	NULL
RIPA	NULL
,	NULL
radioimmunoprecipitation	NULL
assay	NULL
;	NULL
Erk	NULL
,	NULL
extracellular	NULL
signal-regulated	NULL
kinase	NULL
;	NULL
PI3K	NULL
,	NULL
phosphatidylinositol	NULL
3-kinase	NULL
;	NULL
MEK	NULL
,	NULL
MAP/Erk	NULL
kinase	NULL
.	NULL

Copyright	NULL
©	NULL
2001	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
eloid	NULL
stem	NULL
cells	NULL
from	NULL
the	NULL
fetal	NULL
liver	NULL
to	NULL
the	NULL
bone	NULL
marrow	NULL
environment	NULL
(	NULL
17	NULL
,	NULL
19	NULL
)	NULL
.	NULL

SDFla	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
act	NULL
as	NULL
a	NULL
potent	NULL
chemoattractant	NULL
for	NULL
PBLs	NULL
,	NULL
monocytes	NULL
,	NULL
pre-	NULL
and	NULL
pro-B	NULL
cells	NULL
,	NULL
and	NULL
CD34	NULL
*	NULL
human	NULL
progenitors	NULL
(	NULL
6	NULL
,	NULL
11	NULL
,	NULL
20-22	NULL
)	NULL
.	NULL

However	NULL
,	NULL
little	NULL
is	NULL
known	NULL
about	NULL
the	NULL
molecular	NULL
mechanisms	NULL
that	NULL
mediate	NULL
these	NULL
functions	NULL
.	NULL

We	NULL
and	NULL
others	NULL
have	NULL
recently	NULL
shown	NULL
that	NULL
CXCR4	NULL
can	NULL
mediate	NULL
signaling	NULL
through	NULL
various	NULL
components	NULL
of	NULL
the	NULL
focal	NULL
adhesion	NULL
complex	NULL
such	NULL
as	NULL
the	NULL
related	NULL
adhesion	NULL
focal	NULL
tyrosine	NULL
kinase	NULL
(	NULL
RAFTK	NULL
)	NULL
,	NULL
also	NULL
known	NULL
as	NULL
Pyk2	NULL
or	NULL
CAK-B	NULL
(	NULL
23-25	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
we	NULL
also	NULL
showed	NULL
that	NULL
mitogen-activated	NULL
protein	NULL
(	NULL
MAP	NULL
)	NULL
kinase	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
are	NULL
activated	NULL
upon	NULL
SDFla	NULL
stimulation	NULL
(	NULL
23	NULL
)	NULL
.	NULL

Phosphatidylinositol	NULL
3-kinase	NULL
(	NULL
PI3K	NULL
)	NULL
,	NULL
which	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
regulate	NULL
chemotaxis	NULL
(	NULL
26	NULL
)	NULL
,	NULL
is	NULL
also	NULL
involved	NULL
in	NULL
SDFla-induced	NULL
and	NULL
CXCR4-mediated	NULL
chemotaxis	NULL
and	NULL
T	NULL
cell	NULL
migration	NULL
(	NULL
23	NULL
,	NULL
27	NULL
)	NULL
.	NULL

In	NULL
our	NULL
present	NULL
study	NULL
,	NULL
we	NULL
further	NULL
delineate	NULL
the	NULL
signaling	NULL
pathways	NULL
that	NULL
regulate	NULL
CXCR4-mediated	NULL
chemotaxis	NULL
.	NULL

We	NULL
have	NULL
observed	NULL
that	NULL
NO	NULL
and	NULL
NF-B	NULL
are	NULL
key	NULL
components	NULL
of	NULL
the	NULL
SDF1	NULL
&	NULL
-induced	NULL
signaling	NULL
cascade	NULL
.	NULL

NO	NULL
is	NULL
a	NULL
multifunctional	NULL
signaling	NULL
molecule	NULL
that	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
regulate	NULL
various	NULL
cellular	NULL
functions	NULL
such	NULL
as	NULL
hemostasis	NULL
,	NULL
apopto-sis	NULL
,	NULL
inflammation	NULL
,	NULL
vascular	NULL
tone	NULL
,	NULL
and	NULL
chemotaxis	NULL
(	NULL
28-32	NULL
)	NULL
.	NULL

NO	NULL
is	NULL
produced	NULL
from	NULL
L-arginine	NULL
by	NULL
at	NULL
least	NULL
three	NULL
isoforms	NULL
of	NULL
the	NULL
NO	NULL
synthase	NULL
(	NULL
NOS	NULL
)	NULL
enzyme	NULL
:	NULL
type	NULL
I	NULL
(	NULL
neuronal	NULL
NOS	NULL
)	NULL
,	NULL
type	NULL
II	NULL
(	NULL
inducible	NULL
NOS	NULL
)	NULL
,	NULL
and	NULL
type	NULL
III	NULL
(	NULL
endothelial	NULL
NOS	NULL
(	NULL
eNOS	NULL
)	NULL
)	NULL
(	NULL
28-30	NULL
)	NULL
.	NULL

All	NULL
three	NULL
isoforms	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
expressed	NULL
at	NULL
very	NULL
low	NULL
levels	NULL
in	NULL
different	NULL
types	NULL
of	NULL
T	NULL
cells	NULL
(	NULL
33-36	NULL
)	NULL
.	NULL

The	NULL
activity	NULL
of	NULL
NOS	NULL
can	NULL
be	NULL
regulated	NULL
by	NULL
its	NULL
phosphorylation	NULL
and	NULL
by	NULL
other	NULL
posttranslational	NULL
modifications	NULL
.	NULL

It	NULL
has	NULL
been	NULL
shown	NULL
that	NULL
AKT/protein	NULL
kinase	NULL
B	NULL
can	NULL
phosphorylate	NULL
eNOS	NULL
on	NULL
serine	NULL
1179	NULL
,	NULL
which	NULL
leads	NULL
to	NULL
enzyme	NULL
activation	NULL
and	NULL
NO	NULL
production	NULL
(	NULL
37-39	NULL
)	NULL
.	NULL

NO	NULL
modulates	NULL
the	NULL
functions	NULL
of	NULL
various	NULL
proteins	NULL
by	NULL
nitrosylation	NULL
and	NULL
other	NULL
posttranslational	NULL
changes	NULL
(	NULL
40	NULL
)	NULL
.	NULL

NE-	NULL
«	NULL
B	NULL
is	NULL
a	NULL
major	NULL
transcription	NULL
factor	NULL
that	NULL
regulates	NULL
transcription	NULL
of	NULL
genes	NULL
encoding	NULL
many	NULL
inflammatory	NULL
cytokines	NULL
and	NULL
cell	NULL
adhesion	NULL
molecules	NULL
(	NULL
41	NULL
)	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
influence	NULL
NO	NULL
production	NULL
by	NULL
regulating	NULL
expression	NULL
of	NULL
the	NULL
inducible	NULL
NO	NULL
synthase	NULL
gene	NULL
0022-1767/01/	NULL
$	NULL
02.00	NULL
6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
3068	NULL
(	NULL
42	NULL
)	NULL
.	NULL

Conversely	NULL
,	NULL
NO	NULL
has	NULL
also	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
capable	NULL
of	NULL
modulating	NULL
NF-KB	NULL
function	NULL
in	NULL
mononuclear	NULL
leukocytes	NULL
and	NULL
endothelial	NULL
cells	NULL
(	NULL
43	NULL
,	NULL
44	NULL
)	NULL
.	NULL

Although	NULL
NO	NULL
can	NULL
regulate	NULL
migration	NULL
in	NULL
several	NULL
cell	NULL
types	NULL
(	NULL
45-48	NULL
)	NULL
,	NULL
its	NULL
role	NULL
in	NULL
chemokine-mediated	NULL
chemotaxis	NULL
in	NULL
T	NULL
cells	NULL
is	NULL
not	NULL
known	NULL
.	NULL

We	NULL
now	NULL
report	NULL
that	NULL
SDF1a	NULL
&	NULL
treatment	NULL
activates	NULL
NOS	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

Furthermore	NULL
,	NULL
NO	NULL
donors	NULL
enhance	NULL
SDF1	NULL
«	NULL
-induced	NULL
chemotaxis	NULL
,	NULL
whereas	NULL
NO	NULL
inhibitors	NULL
potently	NULL
abrogate	NULL
this	NULL
chemotaxis	NULL
.	NULL

SDFla	NULL
stimulation	NULL
also	NULL
induces	NULL
AKT	NULL
phosphorylation	NULL
.	NULL

These	NULL
studies	NULL
provide	NULL
new	NULL
information	NULL
regarding	NULL
signaling	NULL
pathways	NULL
that	NULL
are	NULL
involved	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
chemokine-induced	NULL
chemotaxis	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Materials	NULL
and	NULL
Methods	NULL
Reagents	NULL
and	NULL
materials	NULL
The	NULL
NO	NULL
donors	NULL
S-nitroso-N-acetyl	NULL
penicillamine	NULL
(	NULL
SNAP	NULL
)	NULL
,	NULL
sodium	NULL
nitro-prusside	NULL
(	NULL
SNP	NULL
)	NULL
,	NULL
and	NULL
4-phenyl-3-furoxancarbonitrite	NULL
(	NULL
PFC	NULL
)	NULL
;	NULL
the	NULL
protease	NULL
inhibitor	NULL
N*-tosyl-lysine-chloromethylketone	NULL
(	NULL
TLCK	NULL
)	NULL
;	NULL
the	NULL
NOS	NULL
inhibitors	NULL
NO-nitro-L-arginine	NULL
methyl	NULL
ester	NULL
(	NULL
L-NAME	NULL
)	NULL
and	NULL
NC-monomethyl-t-argi-nine	NULL
monoacetate	NULL
(	NULL
L-NMMA	NULL
)	NULL
;	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
inhibitors	NULL
N*-tosyl-phenylala-nine-chloromethylketone	NULL
(	NULL
TPCK	NULL
)	NULL
chemical	NULL
inhibitor	NULL
and	NULL
the	NULL
cell	NULL
permeable	NULL
peptide	NULL
inhibitor	NULL
(	NULL
SN50	NULL
)	NULL
;	NULL
and	NULL
the	NULL
cell	NULL
permeable	NULL
inactive	NULL
control	NULL
peptide	NULL
(	NULL
SN5OM	NULL
)	NULL
were	NULL
obtained	NULL
from	NULL
Calbiochem	NULL
(	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Purified	NULL
Abs	NULL
to	NULL
phosphospecific	NULL
p44/42	NULL
MAP	NULL
kinase	NULL
were	NULL
obtained	NULL
from	NULL
New	NULL
England	NULL
Biolabs	NULL
(	NULL
Beverly	NULL
,	NULL
MA	NULL
)	NULL
.	NULL

Protein	NULL
Abs	NULL
to	NULL
p44/42	NULL
were	NULL
obtained	NULL
from	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
(	NULL
Santa	NULL
Cruz	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

The	NULL
NOS	NULL
Detect	NULL
Assay	NULL
kit	NULL
was	NULL
obtained	NULL
from	NULL
Stratagene	NULL
(	NULL
La	NULL
Jolla	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Phospho-AKT	NULL
and	NULL
AKT	NULL
Abs	NULL
were	NULL
obtained	NULL
from	NULL
New	NULL
England	NULL
Biolabs	NULL
.	NULL

Electrophoresis	NULL
reagents	NULL
and	NULL
nitrocellulose	NULL
membrane	NULL
were	NULL
obtained	NULL
from	NULL
Bio-Rad	NULL
(	NULL
Hercules	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

The	NULL
protease	NULL
inhibitors	NULL
leupeptin	NULL
and	NULL
a1	NULL
antitrypsin	NULL
,	NULL
and	NULL
all	NULL
other	NULL
reagents	NULL
,	NULL
were	NULL
obtained	NULL
from	NULL
Sigma	NULL
(	NULL
St.	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
.	NULL

Cell	NULL
culture	NULL
The	NULL
Jurkat	NULL
T	NULL
cell	NULL
line	NULL
was	NULL
cultured	NULL
at	NULL
37°C	NULL
in	NULL
5	NULL
%	NULL
CO	NULL
,	NULL
in	NULL
RPMI	NULL
1640	NULL
with	NULL
10	NULL
%	NULL
FCS	NULL
,	NULL
2	NULL
mM	NULL
glutamine	NULL
,	NULL
50	NULL
pg/ml	NULL
penicillin	NULL
,	NULL
and	NULL
50	NULL
pg/ml	NULL
streptomycin	NULL
.	NULL

Stimulation	NULL
of	NULL
cells	NULL
Jurkat	NULL
cells	NULL
were	NULL
washed	NULL
twice	NULL
with	NULL
1X	NULL
HBSS	NULL
(	NULL
Mediatech	NULL
Laboratories	NULL
,	NULL
Cody	NULL
,	NULL
NY	NULL
)	NULL
,	NULL
then	NULL
resuspended	NULL
at	NULL
10	NULL
X	NULL
10°	NULL
cells/ml	NULL
in	NULL
1	NULL
X	NULL
HBSS	NULL
and	NULL
starved	NULL
for	NULL
1	NULL
h	NULL
at	NULL
37°C	NULL
in	NULL
5	NULL
%	NULL
CO	NULL
,	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
then	NULL
preincubated	NULL
with	NULL
various	NULL
NO	NULL
donors	NULL
,	NULL
NOS	NULL
inhibitors	NULL
,	NULL
or	NULL
the	NULL
NF-KB	NULL
inhibitor	NULL
along	NULL
with	NULL
the	NULL
appropriate	NULL
control	NULL
solvents	NULL
for	NULL
30-60	NULL
min	NULL
at	NULL
37°C	NULL
.	NULL

Following	NULL
this	NULL
treatment	NULL
,	NULL
Jurkat	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
100	NULL
ng/ml	NULL
SDF1	NULL
@	NULL
.	NULL

After	NULL
stimulation	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
microfuged	NULL
for	NULL
10	NULL
s	NULL
and	NULL
lysed	NULL
with	NULL
modified	NULL
radicimmunopre-cipitation	NULL
assay	NULL
(	NULL
RIPA	NULL
)	NULL
buffer	NULL
(	NULL
50	NULL
mM	NULL
Tris-HC	NULL
]	NULL
(	NULL
pH	NULL
7.4	NULL
)	NULL
,	NULL
1	NULL
%	NULL
Nonidet	NULL
P-40	NULL
,	NULL
150	NULL
mM	NULL
NaCl	NULL
,	NULL
200	NULL
mM	NULL
PMSF	NULL
,	NULL
10	NULL
ug/ml	NULL
!	NULL

aprotinin	NULL
,	NULL
1	NULL
pg/ml	NULL
each	NULL
of	NULL
leupeptin	NULL
and	NULL
pepstatin	NULL
,	NULL
2	NULL
mM	NULL
each	NULL
of	NULL
sodium	NULL
vanadate	NULL
and	NULL
sodium	NULL
flu-oride	NULL
,	NULL
and	NULL
0.25	NULL
M	NULL
sodium	NULL
pyrophosphate	NULL
)	NULL
.	NULL

Total	NULL
cell	NULL
lysates	NULL
were	NULL
clarified	NULL
by	NULL
centrifugation	NULL
at	NULL
10,000	NULL
X	NULL
g	NULL
for	NULL
10	NULL
min	NULL
.	NULL

Protein	NULL
amounts	NULL
were	NULL
determined	NULL
by	NULL
a	NULL
protein	NULL
assay	NULL
(	NULL
Bio-Rad	NULL
)	NULL
to	NULL
normalize	NULL
the	NULL
concentrations	NULL
in	NULL
all	NULL
of	NULL
the	NULL
samples	NULL
.	NULL

Isolation	NULL
of	NULL
PBLs	NULL
PBLs	NULL
were	NULL
isolated	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
49	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
PBLs	NULL
were	NULL
isolated	NULL
from	NULL
heparinized	NULL
venous	NULL
blood	NULL
collected	NULL
from	NULL
healthy	NULL
donors	NULL
by	NULL
Ficoll-Hypaque	NULL
density	NULL
gradient	NULL
centrifugation	NULL
at	NULL
3000	NULL
rpm	NULL
for	NULL
25	NULL
min	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
suspended	NULL
in	NULL
RPMI	NULL
1640	NULL
containing	NULL
10	NULL
%	NULL
FCS	NULL
,	NULL
2	NULL
mM	NULL
glutamine	NULL
,	NULL
50	NULL
pg/ml	NULL
penicillin	NULL
,	NULL
and	NULL
50	NULL
ug/ml	NULL
streptomycin	NULL
.	NULL

Monocytes	NULL
were	NULL
depleted	NULL
by	NULL
two	NULL
rounds	NULL
of	NULL
adherence	NULL
to	NULL
plastic	NULL
.	NULL

Nonadherent	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
PHA	NULL
(	NULL
5	NULL
pg/ml	NULL
!	NULL
)	NULL

for	NULL
3	NULL
days	NULL
.	NULL

Cells	NULL
were	NULL
removed	NULL
to	NULL
fresh	NULL
medium	NULL
supplemented	NULL
with	NULL
recombinant	NULL
human	NULL
IL-2	NULL
(	NULL
Advanced	NULL
Biotechnologies	NULL
,	NULL
Columbia	NULL
,	NULL
MD	NULL
)	NULL
.	NULL

Two-week-old	NULL
cells	NULL
were	NULL
used	NULL
for	NULL
the	NULL
chemotaxis	NULL
assays	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
any	NULL
of	NULL
the	NULL
added	NULL
agents	NULL
were	NULL
toxic	NULL
,	NULL
the	NULL
viability	NULL
of	NULL
the	NULL
cells	NULL
following	NULL
various	NULL
treatments	NULL
was	NULL
monitored	NULL
by	NULL
trypan	NULL
blue	NULL
uptake	NULL
.	NULL

No	NULL
toxicity	NULL
was	NULL
observed	NULL
.	NULL

Each	NULL
chemotaxis	NULL
assay	NULL
was	NULL
done	NULL
in	NULL
triplicate	NULL
and	NULL
each	NULL
experiment	NULL
was	NULL
repeated	NULL
twice	NULL
.	NULL

Immunoprecipitation	NULL
Immunoprecipitation	NULL
analysis	NULL
was	NULL
done	NULL
as	NULL
described	NULL
elsewhere	NULL
(	NULL
50	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
equivalent	NULL
amounts	NULL
of	NULL
protein	NULL
from	NULL
each	NULL
sample	NULL
were	NULL
precleared	NULL
by	NULL
incubating	NULL
with	NULL
protein	NULL
A-Sepharose	NULL
CL-4B	NULL
(	NULL
Amersham	NULL
Pharmacia	NULL
NO	NULL
MEDIATES	NULL
SDFia	NULL
@	NULL
-INDUCED	NULL
CHEMOTAXIS	NULL
Biotech	NULL
,	NULL
Piscataway	NULL
,	NULL
NJ	NULL
)	NULL
for	NULL
1	NULL
h	NULL
at	NULL
4°C	NULL
.	NULL

The	NULL
supernatant	NULL
from	NULL
each	NULL
sample	NULL
was	NULL
collected	NULL
after	NULL
brief	NULL
centrifugation	NULL
.	NULL

Primary	NULL
Ab	NULL
was	NULL
added	NULL
for	NULL
each	NULL
experiment	NULL
,	NULL
and	NULL
samples	NULL
were	NULL
incubated	NULL
at	NULL
4°C	NULL
for	NULL
4	NULL
h	NULL
or	NULL
overnight	NULL
.	NULL

The	NULL
immune	NULL
complexes	NULL
were	NULL
precipitated	NULL
with	NULL
50	NULL
pl	NULL
of	NULL
protein	NULL
A-Sepharose	NULL
CL-4B	NULL
(	NULL
50	NULL
%	NULL
suspension	NULL
)	NULL
.	NULL

Nonspecific	NULL
bound	NULL
proteins	NULL
were	NULL
removed	NULL
by	NULL
washing	NULL
the	NULL
Sepharose	NULL
beads	NULL
three	NULL
times	NULL
with	NULL
modified	NULL
RIPA	NULL
buffer	NULL
and	NULL
once	NULL
with	NULL
1	NULL
X	NULL
PBS	NULL
.	NULL

The	NULL
immune	NULL
complexes	NULL
were	NULL
subjected	NULL
to	NULL
MAP	NULL
kinase	NULL
assay	NULL
.	NULL

Western	NULL
blotting	NULL
Western	NULL
blot	NULL
analyses	NULL
were	NULL
done	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
50	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
equivalent	NULL
amounts	NULL
of	NULL
protein	NULL
from	NULL
each	NULL
sample	NULL
were	NULL
run	NULL
on	NULL
8	NULL
%	NULL
SDS-PAGE	NULL
and	NULL
transferred	NULL
to	NULL
nitrocellulose	NULL
membranes	NULL
.	NULL

The	NULL
membranes	NULL
were	NULL
blocked	NULL
with	NULL
5	NULL
%	NULL
nonfat	NULL
dry	NULL
milk	NULL
and	NULL
incubated	NULL
with	NULL
primary	NULL
Ab	NULL
for	NULL
2	NULL
h	NULL
at	NULL
room	NULL
temperature	NULL
or	NULL
overnight	NULL
at	NULL
4°C	NULL
.	NULL

The	NULL
blots	NULL
were	NULL
washed	NULL
and	NULL
incubated	NULL
with	NULL
secondary	NULL
Ab	NULL
coupled	NULL
to	NULL
HRP	NULL
for	NULL
2	NULL
h	NULL
at	NULL
room	NULL
temperature	NULL
or	NULL
overnight	NULL
at	NULL
4°C	NULL
.	NULL

The	NULL
bands	NULL
were	NULL
visualized	NULL
by	NULL
using	NULL
the	NULL
ECL	NULL
system	NULL
(	NULL
Amersham	NULL
Pharmacia	NULL
Biotech	NULL
)	NULL
.	NULL

The	NULL
data	NULL
shown	NULL
are	NULL
representative	NULL
of	NULL
findings	NULL
from	NULL
three	NULL
experiments	NULL
.	NULL

The	NULL
activity	NULL
of	NULL
the	NULL
bands	NULL
was	NULL
quantified	NULL
by	NULL
densitometric	NULL
analysis	NULL
using	NULL
a	NULL
Bio-Rad	NULL
Imager	NULL
.	NULL

The	NULL
mean	NULL
densities	NULL
of	NULL
the	NULL
bands	NULL
are	NULL
represented	NULL
as	NULL
the	NULL
OD	NULL
in	NULL
units	NULL
per	NULL
square	NULL
millimeter	NULL
.	NULL

Chemotaxis	NULL
assays	NULL
Assays	NULL
were	NULL
done	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
23	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
Jurkat	NULL
cells	NULL
were	NULL
washed	NULL
twice	NULL
and	NULL
10	NULL
X	NULL
10°	NULL
cells/ml	NULL
were	NULL
suspended	NULL
in	NULL
medium	NULL
containing	NULL
RPMI	NULL
1640	NULL
with	NULL
2.5	NULL
%	NULL
FCS	NULL
.	NULL

The	NULL
chemotaxis	NULL
assay	NULL
was	NULL
performed	NULL
in	NULL
24-well	NULL
plates	NULL
containing	NULL
5-um	NULL
porosity	NULL
inserts	NULL
(	NULL
Costar	NULL
,	NULL
Kennebunk	NULL
,	NULL
ME	NULL
)	NULL
.	NULL

Before	NULL
performing	NULL
the	NULL
chemotaxis	NULL
assays	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
different	NULL
concentrations	NULL
of	NULL
NO	NULL
donors	NULL
,	NULL
NOS	NULL
inhibitors	NULL
,	NULL
NF-KB	NULL
inhibitor	NULL
,	NULL
or	NULL
the	NULL
appropriate	NULL
controls	NULL
for	NULL
30-60	NULL
min	NULL
.	NULL

One	NULL
hundred	NULL
microliters	NULL
(	NULL
1	NULL
X	NULL
10°	NULL
cells	NULL
)	NULL
from	NULL
each	NULL
sample	NULL
were	NULL
loaded	NULL
onto	NULL
the	NULL
upper	NULL
well	NULL
.	NULL

A	NULL
total	NULL
of	NULL
0.6	NULL
ml	NULL
of	NULL
medium	NULL
containing	NULL
SDF1	NULL
«	NULL
(	NULL
50	NULL
ng/m	NULL
!	NULL
)	NULL

was	NULL
added	NULL
to	NULL
the	NULL
lower	NULL
chamber	NULL
.	NULL

The	NULL
plates	NULL
were	NULL
incubated	NULL
for	NULL
1.5-3	NULL
h	NULL
at	NULL
37°C	NULL
in	NULL
5	NULL
%	NULL
CO	NULL
;	NULL
.	NULL

After	NULL
incubation	NULL
,	NULL
the	NULL
porosity	NULL
inserts	NULL
were	NULL
removed	NULL
carefully	NULL
and	NULL
the	NULL
viable	NULL
cells	NULL
were	NULL
counted	NULL
using	NULL
standard	NULL
procedures	NULL
.	NULL

The	NULL
results	NULL
are	NULL
expressed	NULL
as	NULL
the	NULL
number	NULL
of	NULL
cells	NULL
migrated	NULL
to	NULL
the	NULL
bottom	NULL
chamber	NULL
.	NULL

Each	NULL
experiment	NULL
was	NULL
performed	NULL
three	NULL
or	NULL
four	NULL
times	NULL
in	NULL
triplicate	NULL
.	NULL

p44/42	NULL
MAP	NULL
kinase	NULL
assay	NULL
Cells	NULL
were	NULL
stimulated	NULL
as	NULL
described	NULL
above	NULL
.	NULL

After	NULL
normalizing	NULL
the	NULL
protein	NULL
concentration	NULL
,	NULL
the	NULL
cell	NULL
lysates	NULL
were	NULL
immunoprecipitated	NULL
with	NULL
extracellular	NULL
signal-regulated	NULL
kinase	NULL
(	NULL
Erk	NULL
)	NULL
-1	NULL
and	NULL
Erk-2	NULL
Abs	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
)	NULL
.	NULL

The	NULL
immune	NULL
complexes	NULL
were	NULL
washed	NULL
twice	NULL
with	NULL
RIPA	NULL
buffer	NULL
and	NULL
twice	NULL
with	NULL
kinase	NULL
buffer	NULL
(	NULL
50	NULL
mM	NULL
HEPES	NULL
(	NULL
pH	NULL
7.4	NULL
)	NULL
,	NULL
10	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
and	NULL
20	NULL
uM	NULL
ATP	NULL
)	NULL
.	NULL

Finally	NULL
,	NULL
the	NULL
immune	NULL
complexes	NULL
were	NULL
incubated	NULL
in	NULL
a	NULL
total	NULL
volume	NULL
of	NULL
25	NULL
ul	NULL
of	NULL
kinase	NULL
buffer	NULL
containing	NULL
7	NULL
pug	NULL
of	NULL
myelin	NULL
basic	NULL
protein	NULL
(	NULL
Upstate	NULL
Biotechnology	NULL
,	NULL
Lake	NULL
Placid	NULL
,	NULL
NY	NULL
)	NULL
and	NULL
5	NULL
Ci	NULL
of	NULL
[	NULL
y-*°P	NULL
]	NULL
ATP	NULL
for	NULL
20	NULL
min	NULL
at	NULL
30°C	NULL
.	NULL

The	NULL
proteins	NULL
were	NULL
separated	NULL
on	NULL
15	NULL
%	NULL
SDS-PAGE	NULL
and	NULL
bands	NULL
were	NULL
detected	NULL
by	NULL
autoradiography	NULL
.	NULL

NOS	NULL
assay	NULL
This	NULL
assay	NULL
was	NULL
performed	NULL
by	NULL
using	NULL
the	NULL
NOS	NULL
Detect	NULL
Assay	NULL
kit	NULL
(	NULL
Stratagene	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
washed	NULL
once	NULL
with	NULL
1X	NULL
PBS	NULL
containing	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
suspended	NULL
in	NULL
1X	NULL
homogenization	NULL
buffer	NULL
,	NULL
and	NULL
then	NULL
homogenized	NULL
by	NULL
repeated	NULL
freezing	NULL
and	NULL
thawing	NULL
in	NULL
dry	NULL
ice	NULL
.	NULL

The	NULL
soluble	NULL
fraction	NULL
was	NULL
separated	NULL
by	NULL
centrifugation	NULL
at	NULL
10,000	NULL
%	NULL
g	NULL
for	NULL
5	NULL
min	NULL
,	NULL
normalized	NULL
for	NULL
protein	NULL
concentration	NULL
,	NULL
and	NULL
used	NULL
for	NULL
estimation	NULL
of	NULL
NOS	NULL
activity	NULL
according	NULL
to	NULL
the	NULL
instructions	NULL
of	NULL
the	NULL
man-ufacturer	NULL
.	NULL

Briefly	NULL
,	NULL
the	NULL
cell	NULL
lysate	NULL
(	NULL
5-10	NULL
ug	NULL
protein	NULL
)	NULL
was	NULL
added	NULL
to	NULL
the	NULL
reaction	NULL
mixture	NULL
which	NULL
contained	NULL
the	NULL
substrate	NULL
buffer	NULL
(	NULL
Tris	NULL
buffer	NULL
(	NULL
pH	NULL
74	NULL
)	NULL
,	NULL
6	NULL
uM	NULL
tetrahydrobiopterin	NULL
,	NULL
2	NULL
M	NULL
flavin	NULL
adenine	NULL
dinucleotide	NULL
,	NULL
2	NULL
uM	NULL
flavin	NULL
adenine	NULL
mononucleotide	NULL
)	NULL
,	NULL
6	NULL
mM	NULL
calcium	NULL
chloride	NULL
,	NULL
and	NULL
10	NULL
mM	NULL
NADPH	NULL
.	NULL

The	NULL
samples	NULL
were	NULL
then	NULL
incubated	NULL
for	NULL
30	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

After	NULL
termination	NULL
of	NULL
the	NULL
reaction	NULL
,	NULL
the	NULL
reaction	NULL
product	NULL
,	NULL
citrulline	NULL
,	NULL
was	NULL
separated	NULL
from	NULL
L-arginine	NULL
using	NULL
a	NULL
resin	NULL
that	NULL
specifically	NULL
binds	NULL
to	NULL
L-arginine	NULL
,	NULL
and	NULL
the	NULL
radioactivity	NULL
was	NULL
then	NULL
counted	NULL
.	NULL

NOS	NULL
activity	NULL
is	NULL
expressed	NULL
as	NULL
cpm/h/mg	NULL
protein	NULL
.	NULL

Statistical	NULL
analysis	NULL
The	NULL
results	NULL
are	NULL
expressed	NULL
as	NULL
the	NULL
mean	NULL
+	NULL
SD	NULL
of	NULL
data	NULL
obtained	NULL
from	NULL
three	NULL
or	NULL
four	NULL
experiments	NULL
performed	NULL
in	NULL
duplicate	NULL
or	NULL
triplicate	NULL
.	NULL

The	NULL
statistical	NULL
significance	NULL
was	NULL
determined	NULL
using	NULL
the	NULL
Student	NULL
?	NULL

test	NULL
.	NULL

Results	NULL
SDF	NULL
la	NULL
enhances	NULL
NOS	NULL
activity	NULL
To	NULL
elucidate	NULL
the	NULL
effect	NULL
of	NULL
SDF1a	NULL
on	NULL
NO	NULL
production	NULL
,	NULL
Jurkat	NULL
T	NULL
cells	NULL
,	NULL
which	NULL
were	NULL
uniformly	NULL
positive	NULL
for	NULL
the	NULL
CXCR4	NULL
receptor	NULL
as	NULL
detected	NULL
by	NULL
6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
FACS	NULL
analysis	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
were	NULL
stimulated	NULL
with	NULL
SDF1	NULL
«	NULL
for	NULL
up	NULL
to	NULL
6	NULL
h.	NULL
NOS	NULL
activity	NULL
,	NULL
which	NULL
catalyzes	NULL
the	NULL
synthesis	NULL
of	NULL
NO	NULL
,	NULL
was	NULL
assessed	NULL
by	NULL
measuring	NULL
the	NULL
conversion	NULL
of	NULL
to	NULL
[	NULL
*HJcitrul-line	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
SDF1a	NULL
treatment	NULL
resulted	NULL
in	NULL
an	NULL
increase	NULL
in	NULL
total	NULL
NOS	NULL
activity	NULL
.	NULL

Maximum	NULL
activity	NULL
was	NULL
obtained	NULL
around	NULL
the	NULL
3-h	NULL
time	NULL
period	NULL
.	NULL

NO	NULL
donors	NULL
enhance	NULL
SDF	NULL
la-mediated	NULL
chemotaxis	NULL
To	NULL
explore	NULL
the	NULL
role	NULL
of	NULL
NO	NULL
in	NULL
SDF1	NULL
&	NULL
-induced	NULL
chemotaxis	NULL
,	NULL
Jurkat	NULL
T	NULL
cells	NULL
were	NULL
pretreated	NULL
with	NULL
the	NULL
different	NULL
NO	NULL
donors	NULL
SNAP	NULL
,	NULL
SNP	NULL
,	NULL
and	NULL
PFC	NULL
in	NULL
a	NULL
concentration-dependent	NULL
manner	NULL
and	NULL
then	NULL
a	NULL
chemotaxis	NULL
assay	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
NO	NULL
donors	NULL
significantly	NULL
enhanced	NULL
chemotaxis	NULL
in	NULL
a	NULL
concentration-dependent	NULL
manner	NULL
.	NULL

There	NULL
was	NULL
about	NULL
a	NULL
60	NULL
%	NULL
increase	NULL
in	NULL
migration	NULL
with	NULL
SNAP	NULL
at	NULL
1000	NULL
nM	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
)	NULL
,	NULL
a	NULL
75	NULL
%	NULL
increase	NULL
with	NULL
SNP	NULL
at	NULL
0.1	NULL
M	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
,	NULL
and	NULL
a	NULL
70	NULL
%	NULL
increase	NULL
with	NULL
PFC	NULL
at	NULL
0.1	NULL
uM	NULL
(	NULL
Fig	NULL
.	NULL

2C	NULL
)	NULL
as	NULL
compared	NULL
with	NULL
the	NULL
solvent	NULL
controls	NULL
.	NULL

SNP	NULL
and	NULL
PFC	NULL
at	NULL
very	NULL
high	NULL
concentrations	NULL
had	NULL
no	NULL
or	NULL
a	NULL
lesser	NULL
effect	NULL
.	NULL

The	NULL
effect	NULL
of	NULL
various	NULL
donors	NULL
on	NULL
the	NULL
viability	NULL
of	NULL
cells	NULL
was	NULL
determined	NULL
.	NULL

No	NULL
effect	NULL
on	NULL
cell	NULL
viability	NULL
using	NULL
various	NULL
compounds	NULL
was	NULL
observed	NULL
under	NULL
these	NULL
conditions	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

NO	NULL
inhibitors	NULL
attenuate	NULL
SDF	NULL
la	NULL
&	NULL
-induced	NULL
chemotaxis	NULL
The	NULL
role	NULL
of	NULL
NO	NULL
in	NULL
SDF1	NULL
«	NULL
-induced	NULL
chemotaxis	NULL
was	NULL
further	NULL
confirmed	NULL
by	NULL
using	NULL
various	NULL
inhibitors	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
pretreatment	NULL
of	NULL
Jurkat	NULL
cells	NULL
with	NULL
the	NULL
NOS	NULL
inhibitors	NULL
L-NMMA	NULL
and	NULL
L-NAME	NULL
,	NULL
and	NULL
TLCK	NULL
which	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
inhibit	NULL
NOS	NULL
gene	NULL
expression	NULL
(	NULL
51-53	NULL
)	NULL
,	NULL
attenuated	NULL
SDF1a	NULL
&	NULL
-induced	NULL
chemotaxis	NULL
in	NULL
a	NULL
dose-dependent	NULL
manner	NULL
.	NULL

L-NMMA	NULL
pretreatment	NULL
resulted	NULL
in	NULL
a	NULL
60-70	NULL
%	NULL
inhibition	NULL
at	NULL
0.1-1.0	NULL
mM	NULL
(	NULL
Fig	NULL
.	NULL

34	NULL
)	NULL
,	NULL
whereas	NULL
L-NAME	NULL
at	NULL
2	NULL
mM	NULL
inhibited	NULL
by	NULL
40	NULL
%	NULL
the	NULL
chemotactic	NULL
response	NULL
induced	NULL
by	NULL
SDF1la	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

Maximum	NULL
inhibition	NULL
(	NULL
90	NULL
%	NULL
)	NULL
was	NULL
achieved	NULL
with	NULL
TLCK	NULL
,	NULL
at	NULL
100	NULL
uM	NULL
(	NULL
Fig	NULL
.	NULL

3C	NULL
)	NULL
.	NULL

These	NULL
NO	NULL
donor	NULL
and	NULL
inhibitor	NULL
studies	NULL
revealed	NULL
that	NULL
NO	NULL
is	NULL
an	NULL
important	NULL
mediator	NULL
of	NULL
chemotactic	NULL
responses	NULL
induced	NULL
by	NULL
the	NULL
«	NULL
chemokine	NULL
SDFla	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

We	NULL
also	NULL
determined	NULL
the	NULL
effect	NULL
of	NULL
various	NULL
inhibitors	NULL
on	NULL
cell	NULL
viability	NULL
to	NULL
rule	NULL
out	NULL
the	NULL
possibility	NULL
that	NULL
the	NULL
observed	NULL
decrease	NULL
in	NULL
chemotaxis	NULL
was	NULL
due	NULL
to	NULL
the	NULL
decrease	NULL
in	NULL
cell	NULL
viability	NULL
.	NULL

No	NULL
effect	NULL
on	NULL
cell	NULL
viability	NULL
using	NULL
various	NULL
inhibitors	NULL
was	NULL
observed	NULL
under	NULL
these	NULL
conditions	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

NF-KB	NULL
inhibitors	NULL
inhibit	NULL
SDF	NULL
la-induced	NULL
chemotaxis	NULL
We	NULL
have	NULL
recently	NULL
shown	NULL
that	NULL
SDF1a	NULL
activates	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
23	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
NOS	NULL
expression	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
regulated	NULL
by	NULL
NF-kB	NULL
.	NULL

To	NULL
2	NULL
16	NULL
3	NULL
©	NULL
3	NULL
14	NULL
cie	NULL
s	NULL
£	NULL
10	NULL
cie	NULL
E	NULL
B	NULL
.	NULL

3	NULL
6	NULL
iz	NULL
2	NULL
4	NULL
§	NULL
&	NULL
2	NULL
7	NULL
.	NULL

0	NULL
1	NULL
3	NULL
6	NULL
Time	NULL
(	NULL
hrs	NULL
)	NULL
FIGURE	NULL
1	NULL
.	NULL

Activation	NULL
of	NULL
NOS	NULL
upon	NULL
SDF1	NULL
@	NULL
stimulation	NULL
of	NULL
Jurkat	NULL
cells	NULL
.	NULL

Cell	NULL
lysates	NULL
were	NULL
obtained	NULL
from	NULL
untreated	NULL
cells	NULL
or	NULL
cells	NULL
stimulated	NULL
with	NULL
SDF1a	NULL
(	NULL
100	NULL
ng/m	NULL
!	NULL
)	NULL

for	NULL
the	NULL
indicated	NULL
times	NULL
.	NULL

The	NULL
samples	NULL
were	NULL
assayed	NULL
for	NULL
NOS	NULL
activity	NULL
by	NULL
measuring	NULL
the	NULL
release	NULL
of	NULL
[	NULL
°H	NULL
]	NULL
}	NULL
L-citrulline	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

The	NULL
activity	NULL
of	NULL
the	NULL
unstimulated	NULL
samples	NULL
was	NULL
subtracted	NULL
from	NULL
the	NULL
total	NULL
activity	NULL
obtained	NULL
from	NULL
the	NULL
SDF1	NULL
«	NULL
-induced	NULL
samples	NULL
.	NULL

The	NULL
results	NULL
presented	NULL
in	NULL
the	NULL
graph	NULL
are	NULL
representative	NULL
of	NULL
three	NULL
experiments	NULL
.	NULL

3069	NULL
determine	NULL
the	NULL
role	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
SDF1	NULL
«	NULL
-induced	NULL
chemotaxis	NULL
,	NULL
we	NULL
used	NULL
the	NULL
NF-KB	NULL
chemical	NULL
inhibitor	NULL
TPCK	NULL
and	NULL
the	NULL
peptide	NULL
inhibitor	NULL
SN50	NULL
.	NULL

These	NULL
inhibitors	NULL
markedly	NULL
attenuated	NULL
SDF	NULL
1	NULL
-induced	NULL
chemotactic	NULL
effects	NULL
in	NULL
a	NULL
concentration-dependent	NULL
manner	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

About	NULL
80	NULL
%	NULL
inhibition	NULL
was	NULL
achieved	NULL
with	NULL
100	NULL
M	NULL
TPCK	NULL
as	NULL
compared	NULL
with	NULL
the	NULL
methanol	NULL
control	NULL
(	NULL
Fig	NULL
.	NULL

44	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
90	NULL
%	NULL
inhibition	NULL
was	NULL
obtained	NULL
with	NULL
the	NULL
SN50	NULL
peptide	NULL
(	NULL
100	NULL
pg/ml	NULL
)	NULL
.	NULL

A	NULL
mutant	NULL
peptide	NULL
,	NULL
SNOM	NULL
,	NULL
which	NULL
does	NULL
not	NULL
affect	NULL
NF-	NULL
«	NULL
B	NULL
activity	NULL
under	NULL
similar	NULL
conditions	NULL
,	NULL
had	NULL
no	NULL
significant	NULL
effects	NULL
on	NULL
SDF1	NULL
-induced	NULL
chemotaxis	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
.	NULL

SN50	NULL
is	NULL
a	NULL
cell	NULL
permeable	NULL
peptide	NULL
inhibitor	NULL
containing	NULL
the	NULL
nuclear	NULL
localization	NULL
sequence	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
component	NULL
p50	NULL
,	NULL
which	NULL
inhibits	NULL
translocation	NULL
of	NULL
NF-KB	NULL
into	NULL
the	NULL
nucleus	NULL
.	NULL

SN5OM	NULL
is	NULL
an	NULL
inactive	NULL
control	NULL
peptide	NULL
with	NULL
substitutions	NULL
of	NULL
two	NULL
amino	NULL
acids	NULL
in	NULL
the	NULL
nuclear	NULL
localization	NULL
sequence	NULL
region	NULL
(	NULL
54	NULL
)	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
NF-	NULL
«	NULL
B	NULL
may	NULL
regulate	NULL
SDFla	NULL
&	NULL
-induced	NULL
chemotaxis	NULL
.	NULL

A	NULL
.	NULL

807	NULL
BW	NULL
ouso	NULL
*	NULL
a	NULL
70	NULL
]	NULL
Usnar	NULL
=	NULL
~	NULL
60	NULL
E	NULL
50	NULL
>	NULL
.	NULL

307	NULL
4	NULL
20	NULL
O	NULL
10	NULL
0	NULL
0	NULL
10	NULL
100	NULL
1000	NULL
SNAP	NULL
(	NULL
nM	NULL
)	NULL
B	NULL
.	NULL

45	NULL
x	NULL
40	NULL
T	NULL
e	NULL
$	NULL
35	NULL
lal	NULL
-	NULL
a	NULL
3	NULL
3	NULL
30	NULL
3	NULL
25	NULL
B	NULL
20	NULL
2	NULL
is	NULL
3	NULL
10	NULL
5	NULL
0	NULL
,	NULL
0	NULL
0.01	NULL
0.1	NULL
1	NULL
10	NULL
100	NULL
SNP	NULL
(	NULL
uM	NULL
)	NULL
C.	NULL
&	NULL
lal	NULL
k-o	NULL
B	NULL
25	NULL
2.	NULL
c	NULL
U	NULL
0	NULL
0.002	NULL
0.02	NULL
JA	NULL
1	NULL
10	NULL
PFC	NULL
(	NULL
uM	NULL
)	NULL
FIGURE	NULL
2	NULL
.	NULL

NO	NULL
donors	NULL
enhance	NULL
the	NULL
SDF1a-induced	NULL
chemotaxis	NULL
of	NULL
Jurkat	NULL
cells	NULL
.	NULL

Cells	NULL
were	NULL
preincubated	NULL
with	NULL
different	NULL
concentrations	NULL
of	NULL
the	NULL
NO	NULL
donors	NULL
SNAP	NULL
(	NULL
4	NULL
)	NULL
,	NULL
SNP	NULL
(	NULL
B	NULL
)	NULL
,	NULL
or	NULL
PFC	NULL
(	NULL
C	NULL
)	NULL
or	NULL
the	NULL
appropriate	NULL
solvent	NULL
as	NULL
a	NULL
control	NULL
for	NULL
30-60	NULL
min	NULL
and	NULL
then	NULL
subjected	NULL
to	NULL
chemotactic	NULL
assay	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
SDF1	NULL
«	NULL
(	NULL
50	NULL
ng/m	NULL
!	NULL
)	NULL

as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

*	NULL
,	NULL
Results	NULL
that	NULL
are	NULL
significantly	NULL
different	NULL
from	NULL
the	NULL
control	NULL
:	NULL
A	NULL
,	NULL
p	NULL
<	NULL
0.05	NULL
;	NULL
B	NULL
,	NULL
p	NULL
<	NULL
0.01	NULL
;	NULL
and	NULL
C	NULL
,	NULL
p	NULL
<	NULL
0.001	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
3070	NULL
A.	NULL
ts	NULL
val	NULL
I	NULL
9	NULL
3	NULL
&	NULL
a	NULL
3	NULL
o	NULL
0	NULL
0.001	NULL
0.01	NULL
4	NULL
1	NULL
L-NMMA	NULL
(	NULL
mM	NULL
)	NULL
B	NULL
.	NULL

40	NULL
S	NULL
``	NULL
30	NULL
!	NULL

k-	NULL
$	NULL
a	NULL
3	NULL
g	NULL
10	NULL
e	NULL
0	NULL
0	NULL
-	NULL
0.001	NULL
0.01	NULL
01	NULL
_	NULL
1	NULL
200	NULL
5	NULL
L-NAME	NULL
(	NULL
mM	NULL
)	NULL
C.	NULL
8	NULL
25	NULL
)	NULL
a	NULL
20-k-	NULL
15	NULL
€	NULL
3	NULL
10	NULL
I	NULL
0	NULL
&	NULL
0	NULL
1	NULL
10	NULL
100	NULL
TLCK	NULL
(	NULL
uM	NULL
)	NULL
FIGURE	NULL
3	NULL
.	NULL

NO	NULL
inhibitors	NULL
abrogate	NULL
SDF1la-induced	NULL
migration	NULL
.	NULL

Jurkat	NULL
cells	NULL
were	NULL
pretreated	NULL
with	NULL
various	NULL
NO	NULL
inhibitors	NULL
such	NULL
as	NULL
L-NMMA	NULL
(	NULL
4	NULL
)	NULL
,	NULL
L-NAME	NULL
(	NULL
B	NULL
)	NULL
,	NULL
or	NULL
TLCK	NULL
(	NULL
C	NULL
)	NULL
for	NULL
60	NULL
min	NULL
.	NULL

Next	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
subjected	NULL
to	NULL
chemotactic	NULL
assay	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
SDF1	NULL
«	NULL
(	NULL
50	NULL
ng/ml	NULL
)	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

*	NULL
,	NULL
Results	NULL
that	NULL
are	NULL
significantly	NULL
different	NULL
from	NULL
the	NULL
control	NULL
:	NULL
A	NULL
,	NULL
p	NULL
<	NULL
0.005	NULL
;	NULL
B	NULL
,	NULL
p	NULL
<	NULL
0.05	NULL
;	NULL
and	NULL
C	NULL
,	NULL
p	NULL
<	NULL
0.005	NULL
.	NULL

MAP	NULL
kinase	NULL
inhibitor	NULL
has	NULL
no	NULL
effect	NULL
on	NULL
SDF	NULL
1a-induced	NULL
chemotaxis	NULL
In	NULL
previous	NULL
studies	NULL
,	NULL
we	NULL
have	NULL
shown	NULL
that	NULL
besides	NULL
chemotactic	NULL
activity	NULL
,	NULL
SDFla	NULL
also	NULL
induced	NULL
MAP	NULL
kinase	NULL
activity	NULL
in	NULL
CXCR4-expressing	NULL
pre-B	NULL
cells	NULL
(	NULL
23	NULL
)	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
further	NULL
assessed	NULL
the	NULL
functional	NULL
role	NULL
of	NULL
the	NULL
MAP	NULL
kinase	NULL
pathway	NULL
in	NULL
SDF1l	NULL
-induced	NULL
chemotaxis	NULL
.	NULL

Jurkat	NULL
cells	NULL
were	NULL
pretreated	NULL
either	NULL
with	NULL
PD98059	NULL
,	NULL
which	NULL
inhibits	NULL
MEK	NULL
kinase	NULL
upstream	NULL
of	NULL
p44/42	NULL
MAP	NULL
kinase	NULL
,	NULL
or	NULL
with	NULL
control	NULL
solvent	NULL
DMSO	NULL
.	NULL

Cell	NULL
migration	NULL
in	NULL
response	NULL
to	NULL
SDF1	NULL
«	NULL
&	NULL
was	NULL
then	NULL
determined	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
PD98059	NULL
at	NULL
various	NULL
concentrations	NULL
did	NULL
not	NULL
inhibit	NULL
SDFl	NULL
&	NULL
-induced	NULL
migration	NULL
.	NULL

These	NULL
studies	NULL
suggest	NULL
that	NULL
the	NULL
MAP	NULL
kinase	NULL
signaling	NULL
pathway	NULL
is	NULL
not	NULL
involved	NULL
in	NULL
the	NULL
chemotaxis	NULL
induced	NULL
by	NULL
SDFl	NULL
a	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Effect	NULL
of	NULL
various	NULL
compounds	NULL
on	NULL
the	NULL
SDF	NULL
1a-induced	NULL
chemotaxis	NULL
of	NULL
activated	NULL
PBL	NULL
s	NULL
We	NULL
also	NULL
confirmed	NULL
the	NULL
effect	NULL
of	NULL
various	NULL
compounds	NULL
on	NULL
the	NULL
SDFla	NULL
&	NULL
-induced	NULL
chemotaxis	NULL
of	NULL
activated	NULL
PBLs	NULL
.	NULL

These	NULL
cells	NULL
were	NULL
found	NULL
to	NULL
be	NULL
~60	NULL
%	NULL
positive	NULL
for	NULL
CXCR4	NULL
by	NULL
FACS	NULL
analysis	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

As	NULL
NO	NULL
MEDIATES	NULL
SDFia	NULL
@	NULL
-INDUCED	NULL
CHEMOTAXIS	NULL
A	NULL
.	NULL

3	NULL
30	NULL
;	NULL
DMethanol	NULL
2	NULL
25	NULL
W	NULL
trcs	NULL
3	NULL
20	NULL
E	NULL
go	NULL
15	NULL
2	NULL
10	NULL
3	NULL
5	NULL
*	NULL
0	NULL
,	NULL
0	NULL
1	NULL
10	NULL
100	NULL
TPCK	NULL
(	NULL
uM	NULL
)	NULL
B	NULL
.	NULL

30	NULL
[	NULL
{	NULL
]	NULL
snsom	NULL
25	NULL
I	NULL
sis	NULL
%	NULL
v-x	NULL
20	NULL
-l	NULL
8	NULL
§	NULL
15	NULL
88	NULL
2	NULL
10	NULL
G	NULL
5	NULL
0	NULL
-	NULL
r	NULL
0	NULL
50	NULL
75	NULL
100	NULL
(	NULL
ug/ml	NULL
)	NULL
FIGURE	NULL
4	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
inhibitors	NULL
block	NULL
migration	NULL
induced	NULL
by	NULL
SDF1	NULL
«	NULL
.	NULL

The	NULL
NF-	NULL
«	NULL
B	NULL
chemical	NULL
inhibitor	NULL
TPCK	NULL
(	NULL
4	NULL
)	NULL
or	NULL
peptide	NULL
inhibitor	NULL
SN5O	NULL
(	NULL
B	NULL
)	NULL
was	NULL
incubated	NULL
with	NULL
cells	NULL
for	NULL
30-60	NULL
min	NULL
.	NULL

An	NULL
appropriate	NULL
solvent	NULL
was	NULL
used	NULL
as	NULL
the	NULL
control	NULL
for	NULL
TPCK	NULL
and	NULL
SN5OM	NULL
(	NULL
a	NULL
mutated	NULL
peptide	NULL
)	NULL
was	NULL
used	NULL
as	NULL
the	NULL
control	NULL
for	NULL
SN50	NULL
.	NULL

Cells	NULL
were	NULL
subjected	NULL
to	NULL
chemotactic	NULL
assay	NULL
for	NULL
3	NULL
h	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
SDF1a	NULL
(	NULL
50	NULL
ng/m	NULL
!	NULL
)	NULL

as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

*	NULL
,	NULL
Results	NULL
that	NULL
are	NULL
significantly	NULL
different	NULL
from	NULL
the	NULL
control	NULL
:	NULL
A	NULL
,	NULL
p	NULL
<	NULL
0.005	NULL
and	NULL
B	NULL
,	NULL
p	NULL
<	NULL
0.005.	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

64	NULL
,	NULL
an	NULL
~20-25	NULL
%	NULL
increase	NULL
in	NULL
chemotaxis	NULL
was	NULL
observed	NULL
with	NULL
the	NULL
NO	NULL
donor	NULL
SNP	NULL
at	NULL
50-100	NULL
nM	NULL
concentrations	NULL
.	NULL

However	NULL
,	NULL
NO	NULL
and	NULL
various	NULL
other	NULL
inhibitors	NULL
significantly	NULL
blocked	NULL
SDF1a-induced	NULL
chemotaxis	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
,	NULL
B-D	NULL
)	NULL
.	NULL

TLCK	NULL
inhibited	NULL
chemotaxis	NULL
by	NULL
90-95	NULL
%	NULL
at	NULL
a	NULL
10	NULL
M	NULL
concentration	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
the	NULL
NF-B	NULL
inhibitor	NULL
TPCK	NULL
(	NULL
10	NULL
uM	NULL
;	NULL
Fig	NULL
.	NULL

6C	NULL
)	NULL
or	NULL
SN50	NULL
(	NULL
100	NULL
ug/ml	NULL
;	NULL
Fig	NULL
.	NULL

619	NULL
)	NULL
inhibited	NULL
~90-95	NULL
%	NULL
of	NULL
the	NULL
PBL	NULL
chemotaxis	NULL
induced	NULL
by	NULL
SDF1l	NULL
«	NULL
as	NULL
compared	NULL
with	NULL
the	NULL
control-treated	NULL
samples	NULL
.	NULL

However	NULL
,	NULL
the	NULL
MEK	NULL
kinase	NULL
inhibitor	NULL
PD98059	NULL
(	NULL
Fig	NULL
.	NULL

6E	NULL
)	NULL
did	NULL
not	NULL
have	NULL
any	NULL
effect	NULL
on	NULL
SDF1a-induced	NULL
chemotaxis	NULL
at	NULL
a	NULL
10	NULL
or	NULL
50	NULL
wM	NULL
concentration	NULL
.	NULL

These	NULL
studies	NULL
further	NULL
confirmed	NULL
that	NULL
NO-linked	NULL
signaling	NULL
pathways	NULL
participate	NULL
in	NULL
SDFla-induced	NULL
chemotaxis	NULL
.	NULL

We	NULL
also	NULL
determined	NULL
the	NULL
effect	NULL
of	NULL
the	NULL
above-mentioned	NULL
compounds	NULL
on	NULL
the	NULL
viability	NULL
of	NULL
PBLs	NULL
.	NULL

No	NULL
effect	NULL
on	NULL
cell	NULL
viability	NULL
was	NULL
observed	NULL
under	NULL
these	NULL
conditions	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

SDF	NULL
Ia	NULL
induces	NULL
AKT	NULL
phosphorylation	NULL
AKT	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
phosphorylate	NULL
eNOS	NULL
and	NULL
mediate	NULL
NO	NULL
production	NULL
during	NULL
vascular	NULL
endothelial	NULL
growth	NULL
factor	NULL
signaling	NULL
(	NULL
37-39	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

7	NULL
,	NULL
stimulation	NULL
with	NULL
SDF1	NULL
«	NULL
increased	NULL
the	NULL
phosphorylation	NULL
of	NULL
AKT	NULL
in	NULL
Jurkat	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

74	NULL
)	NULL
and	NULL
PBLs	NULL
(	NULL
Fig	NULL
.	NULL

7B	NULL
)	NULL
as	NULL
observed	NULL
using	NULL
phospho-AKT	NULL
(	NULL
S473	NULL
)	NULL
-specific	NULL
Ab	NULL
.	NULL

Maximum	NULL
phosphorylation	NULL
was	NULL
observed	NULL
around	NULL
5-10	NULL
min	NULL
of	NULL
stimulation	NULL
.	NULL

Equal	NULL
amounts	NULL
of	NULL
AKT	NULL
protein	NULL
were	NULL
present	NULL
in	NULL
each	NULL
lane	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
,	NULL
bottom	NULL
panels	NULL
)	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
AKT	NULL
may	NULL
regulate	NULL
SDF1a-induced	NULL
NO	NULL
production	NULL
and	NULL
chemotaxis	NULL
.	NULL

NO	NULL
inhibitors	NULL
have	NULL
no	NULL
significant	NULL
effect	NULL
on	NULL
SDF	NULL
1la-induced	NULL
MAP	NULL
kinase	NULL
activity	NULL
In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
also	NULL
determined	NULL
the	NULL
effects	NULL
of	NULL
the	NULL
NO	NULL
inhibitor	NULL
TLCK	NULL
,	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
inhibitor	NULL
SN50	NULL
,	NULL
and	NULL
the	NULL
MEK	NULL
kinase	NULL
inhibitor	NULL
6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
LL	NULL
PD98059	NULL
(	NULL
uM	NULL
)	NULL
a	NULL
&	NULL
[	NULL
_	NULL
]	NULL
pmso	NULL
H	NULL
rooos	NULL
ba	NULL
0	NULL
bd	NULL
o	NULL
in	NULL
P	NULL
l	NULL
Cells	NULL
Migrated	NULL
x	NULL
10*	NULL
n	NULL
in	NULL
&	NULL
©	NULL
50	NULL
FIGURE	NULL
5	NULL
.	NULL

MEK	NULL
kinase	NULL
inhibitor	NULL
PD98059	NULL
does	NULL
not	NULL
inhibit	NULL
SDFle-induced	NULL
chemotaxis	NULL
.	NULL

Jurkat	NULL
cells	NULL
were	NULL
pretreated	NULL
with	NULL
various	NULL
concentrations	NULL
of	NULL
the	NULL
MEK	NULL
kinase	NULL
inhibitor	NULL
PD98059	NULL
,	NULL
or	NULL
DMSO	NULL
as	NULL
a	NULL
solvent	NULL
control	NULL
,	NULL
for	NULL
60	NULL
min	NULL
.	NULL

Cells	NULL
were	NULL
subjected	NULL
to	NULL
chemotactic	NULL
assay	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
SDF1a	NULL
(	NULL
50	NULL
ng/ml	NULL
)	NULL
.	NULL

PD98059	NULL
on	NULL
the	NULL
SDF1	NULL
«	NULL
-induced	NULL
phosphorylation	NULL
of	NULL
Erk-1/2	NULL
protein	NULL
by	NULL
using	NULL
phosphospecific	NULL
(	NULL
Thr	NULL
``	NULL
of	NULL
p44	NULL
and	NULL
Tyr	NULL
``	NULL
``	NULL
*	NULL
of	NULL
p42	NULL
)	NULL
mAb	NULL
and	NULL
also	NULL
estimated	NULL
MAP	NULL
kinase	NULL
activity	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

8	NULL
,	NULL
Aa	NULL
(	NULL
upper	NULL
panel	NULL
)	NULL
and	NULL
8Ab	NULL
,	NULL
TLCK	NULL
pretreatment	NULL
had	NULL
no	NULL
significant	NULL
effect	NULL
(	NULL
only	NULL
a	NULL
10-15	NULL
%	NULL
inhibition	NULL
)	NULL
on	NULL
SDFla-induced	NULL
Erk-1/2	NULL
phosphorylation	NULL
.	NULL

Equivalent	NULL
amounts	NULL
of	NULL
Erk-1/2	NULL
protein	NULL
were	NULL
present	NULL
in	NULL
each	NULL
lane	NULL
(	NULL
Fig	NULL
.	NULL

8Aa	NULL
,	NULL
lower	NULL
panel	NULL
)	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
with	NULL
MAP	NULL
kinase	NULL
activity	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Likewise	NULL
,	NULL
preincubation	NULL
with	NULL
SN50	NULL
did	NULL
not	NULL
inhibit	NULL
SDFl	NULL
&	NULL
-induced	NULL
Erk-1/2	NULL
phosphorylation	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
,	NULL
Ba	NULL
,	NULL
upper	NULL
panel	NULL
,	NULL
and	NULL
8Bb	NULL
)	NULL
and	NULL
activity	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
as	NULL
compared	NULL
with	NULL
the	NULL
control	NULL
inhibitor	NULL
SN50M	NULL
.	NULL

Equivalent	NULL
amounts	NULL
of	NULL
Erk-1/2	NULL
protein	NULL
were	NULL
present	NULL
in	NULL
each	NULL
lane	NULL
(	NULL
Fig	NULL
.	NULL

8Ba	NULL
,	NULL
lower	NULL
panel	NULL
)	NULL
.	NULL

However	NULL
,	NULL
with	NULL
the	NULL
MEK	NULL
kinase	NULL
inhibitor	NULL
PD98059	NULL
,	NULL
60-70	NULL
%	NULL
inhibition	NULL
of	NULL
SDF1	NULL
«	NULL
-induced	NULL
Erk-1/2	NULL
phosphorylation	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
,	NULL
Ca	NULL
,	NULL
upper	NULL
panel	NULL
,	NULL
and	NULL
SCB	NULL
)	NULL
and	NULL
activity	NULL
was	NULL
observed	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Equivalent	NULL
amounts	NULL
of	NULL
Erk-1/2	NULL
protein	NULL
were	NULL
present	NULL
in	NULL
each	NULL
sample	NULL
(	NULL
Fig	NULL
.	NULL

8Ca	NULL
,	NULL
lower	NULL
panel	NULL
)	NULL
.	NULL

Discussion	NULL
The	NULL
a	NULL
chemokine	NULL
SDF1a	NULL
and	NULL
its	NULL
cognate	NULL
receptor	NULL
CXCR4	NULL
have	NULL
recently	NULL
sparked	NULL
substantial	NULL
interest	NULL
because	NULL
of	NULL
their	NULL
role	NULL
in	NULL
embryonic	NULL
development	NULL
,	NULL
immune	NULL
regulation	NULL
,	NULL
and	NULL
HIV	NULL
pathogenesis	NULL
(	NULL
9	NULL
,	NULL
10	NULL
,	NULL
16-19	NULL
)	NULL
.	NULL

These	NULL
molecules	NULL
regulate	NULL
chemotaxis	NULL
and	NULL
cell	NULL
viability	NULL
,	NULL
which	NULL
are	NULL
important	NULL
for	NULL
various	NULL
cellular	NULL
functions	NULL
such	NULL
as	NULL
wound	NULL
repair	NULL
,	NULL
metas-tasis	NULL
,	NULL
inflammation	NULL
,	NULL
angiogenesis	NULL
,	NULL
and	NULL
development	NULL
of	NULL
lymphoid	NULL
tissue	NULL
(	NULL
55-57	NULL
)	NULL
.	NULL

We	NULL
and	NULL
others	NULL
have	NULL
recently	NULL
studied	NULL
signaling	NULL
molecules	NULL
activated	NULL
by	NULL
SDF1a	NULL
(	NULL
23-25	NULL
)	NULL
.	NULL

These	NULL
studies	NULL
have	NULL
shown	NULL
activation	NULL
of	NULL
PI3	NULL
kinase	NULL
and	NULL
focal	NULL
adhesion	NULL
components	NULL
such	NULL
as	NULL
RAFTK/Pyk2	NULL
,	NULL
paxillin	NULL
,	NULL
and	NULL
Crk	NULL
in	NULL
SDF1	NULL
-induced	NULL
signaling	NULL
and	NULL
in	NULL
chemotaxis	NULL
responses	NULL
of	NULL
pre-B	NULL
and	NULL
T	NULL
cells	NULL
(	NULL
23-25	NULL
,	NULL
27	NULL
)	NULL
.	NULL

SDF1la	NULL
was	NULL
also	NULL
shown	NULL
to	NULL
activate	NULL
the	NULL
JAK/STAT	NULL
pathway	NULL
(	NULL
58	NULL
)	NULL
.	NULL

Since	NULL
the	NULL
coordinated	NULL
regulation	NULL
of	NULL
several	NULL
signaling	NULL
components	NULL
is	NULL
required	NULL
for	NULL
mediating	NULL
migration	NULL
,	NULL
we	NULL
have	NULL
further	NULL
explored	NULL
the	NULL
signaling	NULL
mechanisms	NULL
regulating	NULL
SDF1a-induced	NULL
chemotaxis	NULL
.	NULL

NO	NULL
,	NULL
generated	NULL
by	NULL
NOS	NULL
,	NULL
is	NULL
known	NULL
to	NULL
be	NULL
both	NULL
an	NULL
intercellular	NULL
and	NULL
intracellular	NULL
signaling	NULL
messenger	NULL
involved	NULL
in	NULL
multiple	NULL
cellular	NULL
functions	NULL
.	NULL

Pretreatment	NULL
of	NULL
Jurkat	NULL
cells	NULL
or	NULL
PBLs	NULL
with	NULL
NO	NULL
donors	NULL
markedly	NULL
enhanced	NULL
SDF1	NULL
«	NULL
-induced	NULL
chemotaxis	NULL
,	NULL
whereas	NULL
NO	NULL
inhibitors	NULL
significantly	NULL
abrogated	NULL
this	NULL
cell	NULL
migration	NULL
.	NULL

However	NULL
,	NULL
NO	NULL
donors	NULL
SNP	NULL
and	NULL
PFC	NULL
at	NULL
higher	NULL
concentrations	NULL
had	NULL
no	NULL
or	NULL
a	NULL
lesser	NULL
effect	NULL
,	NULL
respectively	NULL
,	NULL
on	NULL
this	NULL
migration	NULL
.	NULL

This	NULL
could	NULL
be	NULL
due	NULL
to	NULL
feedback	NULL
inhibition	NULL
of	NULL
NOS	NULL
,	NULL
since	NULL
various	NULL
NO	NULL
donors	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
attenuate	NULL
NOS	NULL
activity	NULL
in	NULL
a	NULL
concentration-dependent	NULL
manner	NULL
(	NULL
59	NULL
,	NULL
60	NULL
)	NULL
.	NULL

These	NULL
results	NULL
demonstrated	NULL
that	NULL
NO-linked	NULL
signaling	NULL
pathways	NULL
mediate	NULL
SDF1	NULL
-induced	NULL
chemotaxis	NULL
.	NULL

NO	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
have	NULL
opposing	NULL
and	NULL
complex	NULL
effects	NULL
on	NULL
chemotactic	NULL
responses	NULL
exerted	NULL
by	NULL
various	NULL
stimuli	NULL
.	NULL

For	NULL
example	NULL
,	NULL
it	NULL
has	NULL
3071	NULL
A	NULL
.	NULL

D	NULL
40	NULL
[	NULL
C	NULL
]	NULL
snsom	NULL
L	NULL
R	NULL
sso	NULL
&	NULL
2	NULL
:	NULL
30	NULL
x	NULL
E	NULL
E	NULL
a	NULL
&	NULL
§	NULL
,	NULL
20	NULL
&	NULL
=	NULL
B	NULL
a	NULL
a	NULL
3	NULL
10	NULL
o	NULL
0	NULL
0	NULL
50	NULL
100	NULL
0	NULL
50	NULL
100	NULL
SNP	NULL
(	NULL
nM	NULL
)	NULL
(	NULL
ug/ml	NULL
)	NULL
B.	NULL
E	NULL
15	NULL
[	NULL
]	NULL
]	NULL
pmso	NULL
-	NULL
-	NULL
M	NULL
roosose	NULL
&	NULL
2	NULL
x	NULL
x	NULL
3	NULL
10	NULL
E	NULL
8	NULL
2	NULL
s	NULL
e	NULL
3	NULL
3	NULL
u	NULL
0	NULL
0	NULL
1	NULL
10	NULL
0	NULL
10	NULL
50	NULL
TLCK	NULL
(	NULL
uM	NULL
)	NULL
PD98059	NULL
(	NULL
uM	NULL
)	NULL
C.	NULL
15	NULL
[	NULL
J	NULL
pmso	NULL
_	NULL
E	NULL
rrck	NULL
E	NULL
5	NULL
10	NULL
8	NULL
S	NULL
2	NULL
cl	NULL
o	NULL
x	NULL
0	NULL
0	NULL
1	NULL
10	NULL
TPCK	NULL
(	NULL
1M	NULL
)	NULL
FIGURE	NULL
6	NULL
.	NULL

Effect	NULL
of	NULL
various	NULL
compounds	NULL
on	NULL
SDF1la-induced	NULL
chemotaxis	NULL
in	NULL
PBLs	NULL
.	NULL

Activated	NULL
PBLs	NULL
were	NULL
pretreated	NULL
with	NULL
various	NULL
compounds	NULL
such	NULL
as	NULL
SNP	NULL
(	NULL
4	NULL
)	NULL
,	NULL
TLCK	NULL
(	NULL
B	NULL
)	NULL
,	NULL
TPCK	NULL
(	NULL
C	NULL
)	NULL
,	NULL
SN5O0	NULL
(	NULL
D	NULL
)	NULL
,	NULL
or	NULL
PD98059	NULL
(	NULL
®	NULL
)	NULL
.	NULL

Cells	NULL
pretreated	NULL
for	NULL
30-60	NULL
min	NULL
with	NULL
the	NULL
appropriate	NULL
solvents	NULL
or	NULL
peptide	NULL
(	NULL
SN5OM	NULL
)	NULL
were	NULL
used	NULL
as	NULL
controls	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
subjected	NULL
to	NULL
chemotaxis	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
SDF1	NULL
«	NULL
(	NULL
50	NULL
ng/ml	NULL
)	NULL
for	NULL
1.5-3	NULL
h.	NULL
*	NULL
,	NULL
Results	NULL
that	NULL
are	NULL
significantly	NULL
different	NULL
from	NULL
the	NULL
control	NULL
:	NULL
A	NULL
,	NULL
p	NULL
<	NULL
0.01	NULL
and	NULL
B-D	NULL
,	NULL
p	NULL
<	NULL
0.005.	NULL
been	NULL
shown	NULL
that	NULL
NO	NULL
enhances	NULL
chemotactic	NULL
responses	NULL
in	NULL
some	NULL
cell	NULL
types	NULL
(	NULL
45	NULL
,	NULL
46	NULL
,	NULL
61-63	NULL
)	NULL
upon	NULL
certain	NULL
stimuli	NULL
,	NULL
while	NULL
inhibiting	NULL
cell	NULL
migration	NULL
in	NULL
others	NULL
(	NULL
47	NULL
,	NULL
64	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
NO	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
modulate	NULL
T	NULL
cell	NULL
chemotaxis	NULL
in	NULL
Peyer	NULL
's	NULL
patches	NULL
and	NULL
in	NULL
the	NULL
nonlymphoid	NULL
region	NULL
of	NULL
the	NULL
intestine	NULL
(	NULL
65	NULL
)	NULL
.	NULL

NO	NULL
can	NULL
exert	NULL
its	NULL
effects	NULL
on	NULL
cell	NULL
motility	NULL
through	NULL
the	NULL
modulation	NULL
of	NULL
cytoskeletal	NULL
proteins	NULL
and	NULL
via	NULL
cell	NULL
matrix	NULL
interactions	NULL
(	NULL
66	NULL
,	NULL
67	NULL
)	NULL
.	NULL

The	NULL
cytoskeletal	NULL
proteins	NULL
paxillin	NULL
,	NULL
Crk	NULL
,	NULL
and	NULL
RAFTK/Pyk2	NULL
are	NULL
activated	NULL
upon	NULL
SDF1a	NULL
stimulation	NULL
(	NULL
23-25	NULL
)	NULL
.	NULL

NO	NULL
also	NULL
induces	NULL
the	NULL
tyrosine	NULL
nitration	NULL
of	NULL
the	NULL
cytoskeletal	NULL
protein	NULL
p130cas	NULL
,	NULL
which	NULL
is	NULL
phosphorylated	NULL
by	NULL
SDF1a	NULL
(	NULL
68	NULL
)	NULL
.	NULL

We	NULL
have	NULL
recently	NULL
shown	NULL
that	NULL
SDF1a	NULL
induced	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
in	NULL
CXCR4	NULL
transfectants	NULL
(	NULL
23	NULL
)	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
have	NULL
demonstrated	NULL
that	NULL
NF-	NULL
«	NULL
B	NULL
inhibitors	NULL
abrogate	NULL
SDF1	NULL
&	NULL
-induced	NULL
chemotactic	NULL
effects	NULL
.	NULL

NO-related	NULL
compounds	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
activate	NULL
NF-	NULL
«	NULL
B	NULL
activity	NULL
(	NULL
42	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
regulate	NULL
iNOS	NULL
gene	NULL
expression	NULL
(	NULL
68	NULL
,	NULL
69	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
cell	NULL
migration	NULL
when	NULL
using	NULL
various	NULL
inhibitors	NULL
that	NULL
block	NULL
NF-KB	NULL
activation	NULL
(	NULL
70-72	NULL
)	NULL
.	NULL

PI3	NULL
kinase	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
regulate	NULL
SDF1a-induced	NULL
migration	NULL
,	NULL
which	NULL
in	NULL
turn	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
activate	NULL
AKT	NULL
(	NULL
protein	NULL
kinase	NULL
B	NULL
)	NULL
.	NULL

In	NULL
the	NULL
present	NULL
study	NULL
,	NULL
we	NULL
have	NULL
shown	NULL
that	NULL
SDF1	NULL
a	NULL
enhances	NULL
AKT	NULL
phosphorylation	NULL
.	NULL

Activated	NULL
AKT	NULL
has	NULL
recently	NULL
been	NULL
shown	NULL
to	NULL
phosphorylate	NULL
eNOS	NULL
and	NULL
enhance	NULL
its	NULL
activity	NULL
,	NULL
leading	NULL
to	NULL
NO	NULL
production	NULL
(	NULL
37-39	NULL
)	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
3072	NULL
NO	NULL
MEDIATES	NULL
SDFia	NULL
@	NULL
-INDUCED	NULL
CHEMOTAXIS	NULL
A	NULL
.	NULL

We	NULL
have	NULL
observed	NULL
that	NULL
the	NULL
MAP	NULL
kinase	NULL
inhibitor	NULL
PD98059	NULL
had	NULL
no	NULL
Stim	NULL
.	NULL

SDFia	NULL
effect	NULL
on	NULL
SDF1	NULL
«	NULL
-induced	NULL
chemotaxis	NULL
of	NULL
T	NULL
cells	NULL
,	NULL
whereas	NULL
at	NULL
similar	NULL
Time	NULL
(	NULL
min	NULL
)	NULL
0	NULL
2	NULL
5	NULL
10	NULL
15	NULL
30	NULL
60	NULL
concentrations	NULL
it	NULL
inhibited	NULL
SDF1	NULL
«	NULL
-induced	NULL
MAP	NULL
kinase	NULL
activation	NULL
by	NULL
P-Akt	NULL
-	NULL
»	NULL
mee	NULL
cues	NULL
we	NULL
come	NULL
o	NULL
60-70	NULL
%	NULL
.	NULL

This	NULL
is	NULL
consistent	NULL
with	NULL
recent	NULL
results	NULL
showing	NULL
the	NULL
SDFla-WB	NULL
:	NULL
P-Akt	NULL
induced	NULL
chemotactic	NULL
activity	NULL
of	NULL
stem	NULL
cells	NULL
(	NULL
75	NULL
)	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
the	NULL
MAP	NULL
kinase	NULL
pathway	NULL
is	NULL
not	NULL
involved	NULL
in	NULL
the	NULL
chemotaxis	NULL
in-sm	NULL
.	NULL

-P	NULL
ap	NULL
ap	NULL
apo	NULL
e	NULL
aa	NULL
ts	NULL
duced	NULL
by	NULL
SDF1a	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

However	NULL
,	NULL
in	NULL
some	NULL
cell	NULL
types	NULL
and	NULL
under	NULL
WB	NULL
:	NULL
Akt	NULL
certain	NULL
stimuli	NULL
,	NULL
MAP	NULL
kinase	NULL
signaling	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
regulate	NULL
cell	NULL
motility	NULL
(	NULL
76	NULL
)	NULL
.	NULL

B	NULL
.	NULL

Our	NULL
results	NULL
also	NULL
indicate	NULL
that	NULL
NO	NULL
is	NULL
an	NULL
upstream	NULL
activator	NULL
of	NULL
che-Stim	NULL
.	NULL

SDFla	NULL
Time	NULL
(	NULL
min	NULL
)	NULL
0	NULL
_	NULL
5	NULL
15	NULL
P-Akt	NULL
-	NULL
»	NULL
30	NULL
60	NULL
120	NULL
WB	NULL
:	NULL
P-Akt	NULL
AlL-P	NULL
Wem	NULL
sms	NULL
as	NULL
»	NULL
CB	NULL
wo	NULL
-a	NULL
WB	NULL
:	NULL
Akt	NULL
FIGURE	NULL
7	NULL
.	NULL

SDFla	NULL
induces	NULL
phosphorylation	NULL
of	NULL
AKT	NULL
in	NULL
Jurkat	NULL
cells	NULL
and	NULL
PBLs	NULL
.	NULL

Cell	NULL
lysates	NULL
(	NULL
50	NULL
ug	NULL
)	NULL
obtained	NULL
from	NULL
Jurkat	NULL
cells	NULL
(	NULL
4	NULL
)	NULL
or	NULL
PBLs	NULL
(	NULL
B	NULL
)	NULL
,	NULL
unstimulated	NULL
(	NULL
0	NULL
)	NULL
or	NULL
stimulated	NULL
for	NULL
varying	NULL
time	NULL
periods	NULL
with	NULL
100	NULL
ng/ml	NULL
SDF1	NULL
«	NULL
,	NULL
were	NULL
run	NULL
on	NULL
SDS-PAGE	NULL
and	NULL
immunoblotted	NULL
with	NULL
anti-phospho-AKT	NULL
Ab	NULL
(	NULL
upper	NULL
panels	NULL
)	NULL
.	NULL

The	NULL
blots	NULL
were	NULL
stripped	NULL
and	NULL
reblotted	NULL
with	NULL
AKT	NULL
Ab	NULL
(	NULL
bottom	NULL
panels	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
AKT	NULL
was	NULL
demonstrated	NULL
to	NULL
mediate	NULL
NF-KB	NULL
activation	NULL
(	NULL
73	NULL
,	NULL
74	NULL
)	NULL
induced	NULL
by	NULL
TNF	NULL
and	NULL
platelet-derived	NULL
growth	NULL
factor	NULL
.	NULL

AKT	NULL
was	NULL
also	NULL
shown	NULL
to	NULL
associate	NULL
with	NULL
IxB	NULL
kinase	NULL
and	NULL
to	NULL
phosphorylate	NULL
IB	NULL
kinase	NULL
at	NULL
threonine	NULL
23.	NULL
motactic	NULL
response	NULL
,	NULL
but	NULL
has	NULL
no	NULL
significant	NULL
effect	NULL
on	NULL
MAP	NULL
kinase	NULL
stimulation	NULL
in	NULL
CXCR4-mediated	NULL
signaling	NULL
pathways	NULL
.	NULL

Furthermore	NULL
,	NULL
we	NULL
observed	NULL
that	NULL
MAP	NULL
kinase	NULL
does	NULL
not	NULL
regulate	NULL
NOS	NULL
activity	NULL
as	NULL
PD98059	NULL
(	NULL
a	NULL
specific	NULL
inhibitor	NULL
of	NULL
p44/42	NULL
MAP	NULL
kinase	NULL
)	NULL
at	NULL
a	NULL
50	NULL
M	NULL
concentration	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
NOS	NULL
activity	NULL
induced	NULL
by	NULL
SDF1a	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

However	NULL
,	NULL
NO	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
have	NULL
complex	NULL
and	NULL
opposing	NULL
effects	NULL
on	NULL
the	NULL
MAP	NULL
kinase	NULL
activation	NULL
induced	NULL
by	NULL
various	NULL
stimuli	NULL
.	NULL

For	NULL
example	NULL
,	NULL
it	NULL
has	NULL
been	NULL
shown	NULL
that	NULL
NO	NULL
has	NULL
partial	NULL
or	NULL
no	NULL
effect	NULL
on	NULL
MAP	NULL
kinase	NULL
activation	NULL
under	NULL
certain	NULL
conditions	NULL
(	NULL
77-78	NULL
)	NULL
,	NULL
whereas	NULL
it	NULL
mediates	NULL
this	NULL
activation	NULL
in	NULL
several	NULL
other	NULL
cell	NULL
types	NULL
(	NULL
79-81	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
PD98059	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
inhibit	NULL
the	NULL
expression	NULL
of	NULL
NOS	NULL
(	NULL
82	NULL
,	NULL
83	NULL
)	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
our	NULL
results	NULL
suggest	NULL
that	NULL
NO	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
may	NULL
mediate	NULL
SDF1	NULL
«	NULL
-induced	NULL
chemotactic	NULL
activity	NULL
,	NULL
but	NULL
not	NULL
MAP	NULL
kinase	NULL
activation	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

These	NULL
findings	NULL
provide	NULL
new	NULL
information	NULL
at	NULL
the	NULL
molecular	NULL
level	NULL
on	NULL
the	NULL
signal	NULL
transduction	NULL
pathways	NULL
used	NULL
by	NULL
the	NULL
a	NULL
chemokine	NULL
SDF1a	NULL
and	NULL
its	NULL
receptor	NULL
CXCR4	NULL
to	NULL
regulate	NULL
T	NULL
cell	NULL
migration	NULL
,	NULL
an	NULL
important	NULL
event	NULL
in	NULL
both	NULL
physiological	NULL
and	NULL
pathological	NULL
processes	NULL
.	NULL

A	NULL
.	NULL

*	NULL
_	NULL
gtim	NULL
.	NULL

SDFia	NULL
sprie+1LcKk	NULL
_	NULL
*	NULL
__	NULL
SDFie	NULL
__	NULL
SDFlae+	NULL
TLCK	NULL
Time	NULL
@	NULL
min	NULL
)	NULL
}	NULL
0	NULL
0.5	NULL
-	NULL
5	NULL
20	NULL
0	NULL
05	NULL
5	NULL
20	NULL
s	NULL
$	NULL
2	NULL
U-	NULL
-	NULL
am	NULL
-	NULL
as	NULL
--	NULL
E	NULL
12	NULL
WB	NULL
:	NULL
P-Erk	NULL
1/2	NULL
's	NULL
8	NULL
A	NULL
4	NULL
(	NULL
1	NULL
.	NULL

-P	NULL
#	NULL
s	NULL
aas	NULL
cas	NULL
am	NULL
ear	NULL
an	NULL
can	NULL
ne	NULL
)	NULL
©	NULL
o	NULL
FIGURE	NULL
8	NULL
.	NULL

-	NULL
TLCK	NULL
or	NULL
SN5O	NULL
does	NULL
not	NULL
signif-	NULL
WB	NULL
:	NULL
Erk	NULL
1/2	NULL
Time	NULL
(	NULL
min	NULL
)	NULL
:	NULL
0	NULL
0.5	NULL
5	NULL
20	NULL
O0	NULL
05	NULL
5	NULL
20	NULL
icantly	NULL
inhibit	NULL
SDF1e-induced	NULL
MAP	NULL
kinase	NULL
ac-	NULL
}	NULL
tivity	NULL
.	NULL

Jurkat	NULL
cells	NULL
were	NULL
pretreated	NULL
with	NULL
the	NULL
NO	NULL
inhibitor	NULL
TLCK	NULL
(	NULL
Aa	NULL
and	NULL
Ab	NULL
)	NULL
,	NULL
NF-KB	NULL
inhibitor	NULL
SN50	NULL
(	NULL
Ba	NULL
and	NULL
Bb	NULL
)	NULL
,	NULL
or	NULL
the	NULL
MEK	NULL
kinase	NULL
inhibitor	NULL
B.	NULL
PD98059	NULL
(	NULL
Ca	NULL
and	NULL
Cb	NULL
)	NULL
for	NULL
60	NULL
min	NULL
and	NULL
then	NULL
stimulated	NULL
with	NULL
SDF-10	NULL
(	NULL
100	NULL
ng/m	NULL
!	NULL
)	NULL

for	NULL
the	NULL
indicated	NULL
_	NULL
``	NULL
*	NULL
.	NULL

{	NULL
,	NULL
;	NULL
gprig	NULL
+	NULL
SNSOM	NULL
spria+snso_	NULL
*	NULL
SDFia	NULL
+	NULL
SNSOM	NULL
SDFia+SNSO	NULL
time	NULL
periods	NULL
.	NULL

Cell	NULL
lysates	NULL
(	NULL
50	NULL
ug	NULL
)	NULL
,	NULL
unstimulated	NULL
Time	NULL
(	NULL
min	NULL
}	NULL
0	NULL
05	NULL
-	NULL
5	NULL
-	NULL
20	NULL
o	NULL
05050	NULL
20	NULL
ga	NULL
20	NULL
(	NULL
0	NULL
)	NULL
or	NULL
stimulated	NULL
with	NULL
SDF1	NULL
«	NULL
for	NULL
various	NULL
time	NULL
w	NULL
16	NULL
periods	NULL
,	NULL
were	NULL
separated	NULL
on	NULL
an	NULL
8	NULL
%	NULL
SDS-PAGE	NULL
11:2	NULL
;	NULL
-B	NULL
wie	NULL
ae	NULL
wz	NULL
E.	NULL
12	NULL
gel	NULL
,	NULL
transferred	NULL
onto	NULL
nitrocellulose	NULL
membranes	NULL
,	NULL
WB	NULL
:	NULL
P-Erk	NULL
1/2	NULL
2-5	NULL
8	NULL
and	NULL
probed	NULL
with	NULL
phosphospecific	NULL
anti-p44/42	NULL
p44	NULL
o	NULL
4	NULL
MAP	NULL
kinase	NULL
(	NULL
P-Erk-1/2	NULL
)	NULL
Ab	NULL
(	NULL
Ac-Ca	NULL
,	NULL
upper	NULL
pan-	NULL
[	NULL
-	NULL
-F	NULL
:	NULL
:	NULL
els	NULL
)	NULL
.	NULL

The	NULL
same	NULL
blots	NULL
were	NULL
stripped	NULL
and	NULL
reprobed	NULL
with	NULL
anti-p44/42	NULL
MAP	NULL
kinase	NULL
(	NULL
Erk-1/2	NULL
)	NULL
(	NULL
Ac-Ca	NULL
,	NULL
bottom	NULL
panels	NULL
)	NULL
.	NULL

The	NULL
OD	NULL
values	NULL
obtained	NULL
after	NULL
densitometric	NULL
scanning	NULL
of	NULL
the	NULL
P-Erk-1/2	NULL
bands	NULL
are	NULL
presented	NULL
as	NULL
bar	NULL
graphs	NULL
(	NULL
Ab-Ch	NULL
)	NULL
.	NULL

The	NULL
above	NULL
results	NULL
are	NULL
representative	NULL
of	NULL
three	NULL
experiments	NULL
.	NULL

0	NULL
Time	NULL
(	NULL
min	NULL
}	NULL
:	NULL
O	NULL
0.5	NULL
5	NULL
20	NULL
O0	NULL
0.5	NULL
5	NULL
20	NULL
WB	NULL
:	NULL
Erk	NULL
1/2	NULL
c.	NULL
*	NULL
-	NULL
sgn	NULL
SDFia+DMSO	NULL
_	NULL
*	NULL
SDFia	NULL
+	NULL
DMSO	NULL
SDFia+PD98059	NULL
Time	NULL
(	NULL
miny	NULL
O	NULL
05	NULL
5	NULL
20	NULL
0	NULL
O05	NULL
5	NULL
20	NULL
a	NULL
1	NULL
:	NULL
k-	NULL
!	NULL

1-4	NULL
-	NULL
aes	NULL
go	NULL
3	NULL
5	NULL
WB	NULL
:	NULL
P-Erk	NULL
1/2	NULL
8	NULL
a	NULL
d	NULL
3	NULL
/	NULL
>	NULL
©	NULL
.	NULL

,	NULL
.	NULL

Time	NULL
(	NULL
min	NULL
}	NULL
:	NULL
0	NULL
0.5	NULL
5	NULL
20	NULL
O	NULL
0.5	NULL
5	NULL
20	NULL
WB	NULL
:	NULL
Erk	NULL
1/2	NULL
6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
Acknowledgments	NULL
We	NULL
are	NULL
grateful	NULL
to	NULL
Dr.	NULL
Jerome	NULL
E.	NULL
Groopman	NULL
for	NULL
his	NULL
advice	NULL
and	NULL
support	NULL
for	NULL
our	NULL
research	NULL
project	NULL
.	NULL

We	NULL
thank	NULL
Janet	NULL
Delahanty	NULL
for	NULL
editing	NULL
this	NULL
manuscript	NULL
,	NULL
Daniel	NULL
Kelley	NULL
for	NULL
preparation	NULL
of	NULL
the	NULL
figures	NULL
,	NULL
and	NULL
Simone	NULL
Jadusingh	NULL
for	NULL
facilitating	NULL
receipt	NULL
of	NULL
the	NULL
reagents	NULL
for	NULL
the	NULL
experiments	NULL
.	NULL

References	NULL
L.	NULL
2	NULL
.	NULL

3	NULL
.	NULL

10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

Rollins	NULL
,	NULL
B.	NULL
J	NULL
.	NULL

1997	NULL
.	NULL

Chemokines	NULL
.	NULL

Blood	NULL
90:909	NULL
.	NULL

Premack	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
,	NULL
and	NULL
T.	NULL
J.	NULL
Schall	NULL
.	NULL

1996	NULL
.	NULL

Chemokine	NULL
receptors	NULL
:	NULL
gateways	NULL
to	NULL
inflammation	NULL
and	NULL
infection	NULL
.	NULL

Nat	NULL
.	NULL

Med	NULL
.	NULL

2:1174	NULL
.	NULL

Bokoch	NULL
,	NULL
G.	NULL
M.	NULL
1995	NULL
.	NULL

Chemoattractant	NULL
signaling	NULL
and	NULL
leukocyte	NULL
activation	NULL
.	NULL

Blood	NULL
86	NULL
:	NULL
1649	NULL
.	NULL

Gerard	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
N.	NULL
P.	NULL
Gerard	NULL
.	NULL

1994	NULL
.	NULL

The	NULL
pro-inflammatory	NULL
:	NULL
seven-transmembrane	NULL
segment	NULL
receptors	NULL
of	NULL
the	NULL
leukocyte	NULL
.	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Immunol	NULL
.	NULL

6:140.	NULL
.	NULL

Taub	NULL
,	NULL
D.	NULL
D.	NULL
,	NULL
and	NULL
J.	NULL
J.	NULL
Oppenheim	NULL
.	NULL

1994	NULL
.	NULL

Chemokines	NULL
,	NULL
inflammation	NULL
and	NULL
the	NULL
immune	NULL
system	NULL
.	NULL

Ther	NULL
.	NULL

Immunol	NULL
.	NULL

1:229.	NULL
.	NULL

Luster	NULL
,	NULL
A.	NULL
D.	NULL
1998	NULL
.	NULL

Chemokines-chemotactic	NULL
cytokines	NULL
that	NULL
mediate	NULL
inflammation	NULL
.	NULL

N.	NULL
Engl	NULL
.	NULL

J.	NULL
Med	NULL
.	NULL

338:436.	NULL
.	NULL

Loctscher	NULL
,	NULL
M.	NULL
,	NULL
T.	NULL
Geiser	NULL
,	NULL
T.	NULL
O'Reilly	NULL
,	NULL
R.	NULL
Zwahlen	NULL
,	NULL
M.	NULL
Baggiolini	NULL
,	NULL
and	NULL
B.	NULL
Moser	NULL
.	NULL

1994	NULL
.	NULL

Cloning	NULL
of	NULL
a	NULL
human	NULL
seven-transmembrane	NULL
domain	NULL
receptor	NULL
,	NULL
LESTR	NULL
,	NULL
that	NULL
is	NULL
highly	NULL
expressed	NULL
in	NULL
leukocytes	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269:232.	NULL
.	NULL

Hamada	NULL
,	NULL
T.	NULL
,	NULL
K.	NULL
Tashiro	NULL
,	NULL
H.	NULL
Tada	NULL
,	NULL
J.	NULL
Inazawa	NULL
,	NULL
M.	NULL
Shirozu	NULL
,	NULL
K.	NULL
Shibahara	NULL
,	NULL
T.	NULL
Nakamura	NULL
,	NULL
N.	NULL
Martina	NULL
,	NULL
T.	NULL
Nakano	NULL
,	NULL
and	NULL
T.	NULL
Honjo	NULL
.	NULL

1996	NULL
.	NULL

Isolation	NULL
and	NULL
characterization	NULL
of	NULL
a	NULL
novel	NULL
secretory	NULL
protein	NULL
,	NULL
stromal	NULL
cell-derived	NULL
factor-2	NULL
(	NULL
SDF-2	NULL
)	NULL
using	NULL
the	NULL
signal	NULL
sequence	NULL
trap	NULL
method	NULL
.	NULL

Gene	NULL
176:211.	NULL
.	NULL

Bleul	NULL
,	NULL
C.	NULL
C.	NULL
,	NULL
M.	NULL
Farzan	NULL
,	NULL
H.	NULL
Choe	NULL
,	NULL
C.	NULL
Parolin	NULL
,	NULL
I.	NULL
Clark-Lewis	NULL
,	NULL
J.	NULL
Sodroski	NULL
,	NULL
and	NULL
T.	NULL
A.	NULL
Springer	NULL
.	NULL

1996	NULL
.	NULL

The	NULL
lymphocyte	NULL
chemoattractant	NULL
SDF-1	NULL
is	NULL
a	NULL
ligand	NULL
for	NULL
LESTR/	NULL
fusin	NULL
and	NULL
blocks	NULL
HIV-1	NULL
entry	NULL
.	NULL

Nature	NULL
382:829	NULL
.	NULL

Feng	NULL
,	NULL
Y.	NULL
,	NULL
C.	NULL
C.	NULL
Broder	NULL
,	NULL
P.	NULL
E.	NULL
Kennedy	NULL
,	NULL
and	NULL
E.	NULL
A.	NULL
Berger	NULL
.	NULL

1996	NULL
.	NULL

HIV-1	NULL
entry	NULL
cofactor	NULL
:	NULL
functional	NULL
cDNA	NULL
cloning	NULL
of	NULL
a	NULL
seven-transmembrane	NULL
,	NULL
G	NULL
protein-coupled	NULL
receptor	NULL
.	NULL

Science	NULL
272:872	NULL
.	NULL

Aiuti	NULL
,	NULL
A.	NULL
,	NULL
L	NULL
J.	NULL
Webb	NULL
,	NULL
C.	NULL
Bleul	NULL
,	NULL
T.	NULL
Springer	NULL
,	NULL
and	NULL
J.	NULL
C.	NULL
Gutierez-Ramos	NULL
.	NULL

1997	NULL
.	NULL

The	NULL
chemokine	NULL
SDF-1	NULL
is	NULL
a	NULL
chemoattractant	NULL
for	NULL
human	NULL
CD34	NULL
*	NULL
hematopoietic	NULL
progenitor	NULL
cells	NULL
and	NULL
provides	NULL
a	NULL
new	NULL
mechanism	NULL
to	NULL
explain	NULL
the	NULL
mobilization	NULL
of	NULL
CD34*	NULL
progenitors	NULL
to	NULL
peripheral	NULL
blood	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

185:111	NULL
.	NULL

Forster	NULL
,	NULL
R.	NULL
,	NULL
E.	NULL
Kremmer	NULL
,	NULL
A.	NULL
Schubel	NULL
,	NULL
D.	NULL
Breitfeld	NULL
,	NULL
A.	NULL
Kleinschmidt	NULL
,	NULL
C.	NULL
Ner	NULL
]	NULL
,	NULL
G.	NULL
Bembardt	NULL
,	NULL
and	NULL
M.	NULL
Lipp	NULL
.	NULL

1998	NULL
.	NULL

Intracellular	NULL
and	NULL
surface	NULL
expression	NULL
of	NULL
the	NULL
HIV-1	NULL
coreceptor	NULL
CXCR4/fusin	NULL
on	NULL
various	NULL
leukocyte	NULL
subsets	NULL
:	NULL
rapid	NULL
internalization	NULL
and	NULL
recycling	NULL
upon	NULL
activation	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

160:1522	NULL
.	NULL

Bleul	NULL
,	NULL
C.	NULL
C.	NULL
,	NULL
L.	NULL
Wu	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Hoxie	NULL
,	NULL
T.	NULL
A.	NULL
Springer	NULL
,	NULL
and	NULL
C.	NULL
R.	NULL
Mackay	NULL
.	NULL

1997	NULL
.	NULL

The	NULL
HIV	NULL
coreceptors	NULL
CXCR4	NULL
and	NULL
CCRS	NULL
are	NULL
differentially	NULL
expressed	NULL
and	NULL
regulated	NULL
on	NULL
human	NULL
T	NULL
lymphocytes	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
94:1925	NULL
.	NULL

Hesselgesser	NULL
,	NULL
J.	NULL
,	NULL
M.	NULL
Halks-Millet	NULL
,	NULL
V.	NULL
DelVecchio	NULL
,	NULL
S.	NULL
C.	NULL
Peiper	NULL
,	NULL
J.	NULL
Hoxie	NULL
,	NULL
D.	NULL
L.	NULL
Kolson	NULL
,	NULL
D.	NULL
Taub	NULL
,	NULL
and	NULL
R.	NULL
Horuk	NULL
.	NULL

1997	NULL
.	NULL

CD4-independent	NULL
association	NULL
between	NULL
HIV-1	NULL
gp120	NULL
and	NULL
CXCR4	NULL
:	NULL
functional	NULL
chemokine	NULL
receptors	NULL
are	NULL
expressed	NULL
in	NULL
human	NULL
neurons	NULL
.	NULL

Curr	NULL
.	NULL

Biol	NULL
.	NULL

7:112	NULL
.	NULL

Littman	NULL
,	NULL
D.	NULL
R.	NULL
1998	NULL
.	NULL

Chemokine	NULL
receptors	NULL
:	NULL
keys	NULL
to	NULL
AIDS	NULL
pathogenesis	NULL
?	NULL

Cell	NULL
93:677	NULL
.	NULL

Nagasawa	NULL
,	NULL
T.	NULL
,	NULL
S.	NULL
Hirota	NULL
,	NULL
K.	NULL
Tachibana	NULL
,	NULL
N.	NULL
Takakura	NULL
,	NULL
S.	NULL
Nishikawa	NULL
,	NULL
Y.	NULL
Kitamura	NULL
,	NULL
N.	NULL
Yoshida	NULL
,	NULL
H.	NULL
Kikutani	NULL
,	NULL
and	NULL
T.	NULL
Kishimoto	NULL
.	NULL

1996	NULL
.	NULL

Defects	NULL
of	NULL
B-cell	NULL
lymphopoicsis	NULL
and	NULL
bone-marrow	NULL
myelopoiesis	NULL
in	NULL
mice	NULL
lacking	NULL
the	NULL
CXC	NULL
chemokine	NULL
PBSF/SDF-1	NULL
.	NULL

Nature	NULL
382:635	NULL
.	NULL

Ma	NULL
,	NULL
Q.	NULL
,	NULL
D.	NULL
Jones	NULL
,	NULL
P.	NULL
R.	NULL
Borghesani	NULL
,	NULL
R.	NULL
A.	NULL
Segal	NULL
,	NULL
T.	NULL
Nagasawa	NULL
,	NULL
T.	NULL
Kishimoto	NULL
,	NULL
R.	NULL
T.	NULL
Bronson	NULL
,	NULL
and	NULL
T.	NULL
A.	NULL
Springer	NULL
.	NULL

1998	NULL
.	NULL

Impaired	NULL
B-lymphopoiesis	NULL
,	NULL
myelopoicsis	NULL
,	NULL
and	NULL
derailed	NULL
cerebellar	NULL
neuron	NULL
migration	NULL
in	NULL
CXCR4-	NULL
and	NULL
SDF-1-deficient	NULL
mice	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
95:9448	NULL
.	NULL

Tachibana	NULL
,	NULL
K.	NULL
,	NULL
S.	NULL
Hirota	NULL
,	NULL
H.	NULL
lizasa	NULL
,	NULL
H.	NULL
Yoshida	NULL
,	NULL
K.	NULL
Kawabata	NULL
,	NULL
Y.	NULL
Kataoka	NULL
,	NULL
Y.	NULL
Kitamura	NULL
,	NULL
K.	NULL
Matsushima	NULL
,	NULL
N.	NULL
Yoshida	NULL
,	NULL
S.	NULL
Nishikawa	NULL
,	NULL
T.	NULL
Kishimoto	NULL
,	NULL
and	NULL
T.	NULL
Nagasawa	NULL
.	NULL

1998	NULL
.	NULL

The	NULL
chemokine	NULL
receptor	NULL
CXCR4	NULL
is	NULL
essential	NULL
for	NULL
vascularization	NULL
of	NULL
the	NULL
gastrointestinal	NULL
tract	NULL
.	NULL

Nature	NULL
393:591	NULL
.	NULL

Zou	NULL
,	NULL
Y.	NULL
R.	NULL
,	NULL
A.	NULL
H.	NULL
Kottmann	NULL
,	NULL
M.	NULL
Kuroda	NULL
,	NULL
I.	NULL
Tanfuchi	NULL
,	NULL
and	NULL
D.	NULL
R.	NULL
Littman	NULL
.	NULL

1998	NULL
.	NULL

Function	NULL
of	NULL
the	NULL
chemokine	NULL
receptor	NULL
CXCR4	NULL
in	NULL
haematopoiesis	NULL
and	NULL
in	NULL
cerebellar	NULL
development	NULL
.	NULL

Nature	NULL
393:595	NULL
.	NULL

Hamada	NULL
,	NULL
T.	NULL
,	NULL
R.	NULL
Mobile	NULL
,	NULL
J.	NULL
Hesselgesser	NULL
,	NULL
J.	NULL
Hoxie	NULL
,	NULL
R.	NULL
L.	NULL
Nachman	NULL
,	NULL
M.	NULL
A.	NULL
Moore	NULL
,	NULL
and	NULL
S.	NULL
Rafii	NULL
.	NULL

1998	NULL
.	NULL

Transendothelial	NULL
migration	NULL
of	NULL
megakaryocytes	NULL
in	NULL
response	NULL
to	NULL
stromal	NULL
cell-derived	NULL
factor	NULL
1	NULL
(	NULL
SDF-1	NULL
)	NULL
enhances	NULL
platelet	NULL
formation	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

188:539.	NULL
.	NULL

D'Apuzzo	NULL
,	NULL
M.	NULL
,	NULL
A.	NULL
Rolink	NULL
,	NULL
M.	NULL
Loctscher	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Hoxie	NULL
,	NULL
I.	NULL
Clark-Lewis	NULL
,	NULL
F.	NULL
Melchers	NULL
,	NULL
M.	NULL
Baggiolini	NULL
,	NULL
and	NULL
B.	NULL
Moser	NULL
.	NULL

1997	NULL
.	NULL

The	NULL
chemokine	NULL
SDF-1	NULL
,	NULL
stromal	NULL
cell-derived	NULL
factor	NULL
1	NULL
,	NULL
attracts	NULL
early	NULL
stage	NULL
B	NULL
cell	NULL
precursors	NULL
via	NULL
the	NULL
chemokine	NULL
receptor	NULL
CXCR4	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

27:1788	NULL
.	NULL

Schabath	NULL
,	NULL
R.	NULL
,	NULL
G.	NULL
Muller	NULL
,	NULL
A.	NULL
Schubel	NULL
,	NULL
E.	NULL
Kremmer	NULL
,	NULL
M.	NULL
Lipp	NULL
,	NULL
and	NULL
R.	NULL
Forster	NULL
.	NULL

1999	NULL
.	NULL

The	NULL
murine	NULL
chemokine	NULL
receptor	NULL
CXCR4	NULL
is	NULL
tightly	NULL
regulated	NULL
during	NULL
T	NULL
cell	NULL
development	NULL
and	NULL
activation	NULL
.	NULL

J.	NULL
Leukocyte	NULL
Biol	NULL
.	NULL

66:996	NULL
.	NULL

Ganju	NULL
,	NULL
R.	NULL
K.	NULL
,	NULL
S.	NULL
A.	NULL
Brubaker	NULL
,	NULL
J.	NULL
Meyer	NULL
,	NULL
P.	NULL
Dutt	NULL
,	NULL
Y.	NULL
Yang	NULL
,	NULL
S.	NULL
Qin	NULL
,	NULL
W.	NULL
Newman	NULL
,	NULL
and	NULL
J.	NULL
E.	NULL
Groopman	NULL
.	NULL

1998	NULL
.	NULL

The	NULL
-chemokine	NULL
,	NULL
stromal	NULL
cell-derived	NULL
factor-1	NULL
@	NULL
,	NULL
binds	NULL
to	NULL
the	NULL
transmembrane	NULL
G-protein-coupled	NULL
CXCR-4	NULL
receptor	NULL
and	NULL
activates	NULL
multiple	NULL
signal	NULL
transduction	NULL
pathways	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

273:23169	NULL
.	NULL

Davis	NULL
,	NULL
C.	NULL
B.	NULL
,	NULL
L	NULL
Dikic	NULL
,	NULL
D.	NULL
Unutmaz	NULL
,	NULL
C.	NULL
M.	NULL
Hill	NULL
,	NULL
J.	NULL
Arthos	NULL
,	NULL
M.	NULL
A.	NULL
Siani	NULL
,	NULL
D.	NULL
A.	NULL
Thompson	NULL
,	NULL
J.	NULL
Schlessinger	NULL
,	NULL
and	NULL
D.	NULL
R.	NULL
Littman	NULL
.	NULL

1997	NULL
.	NULL

Signal	NULL
transduction	NULL
due	NULL
to	NULL
HIV-1	NULL
envelope	NULL
interactions	NULL
with	NULL
chemokine	NULL
receptors	NULL
CXCR4	NULL
or	NULL
CCRS	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

186:1793	NULL
.	NULL

Dikic	NULL
,	NULL
I.	NULL
,	NULL
and	NULL
J.	NULL
Schlessinger	NULL
.	NULL

1998	NULL
.	NULL

Identification	NULL
of	NULL
a	NULL
new	NULL
Pyk2	NULL
isoform	NULL
implicated	NULL
in	NULL
chemokine	NULL
and	NULL
antigen	NULL
receptor	NULL
signaling	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

273:14301	NULL
.	NULL

Sasaki	NULL
,	NULL
T.	NULL
,	NULL
J.	NULL
Irie-Sasaki	NULL
,	NULL
R.	NULL
G.	NULL
Jones	NULL
,	NULL
A.	NULL
J.	NULL
Oliveira-dos-Santos	NULL
,	NULL
W.	NULL
L.	NULL
Stanford	NULL
,	NULL
B.	NULL
Bolon	NULL
,	NULL
A.	NULL
Wakeham	NULL
,	NULL
A.	NULL
Itie	NULL
,	NULL
D.	NULL
Bouchard	NULL
,	NULL
et	NULL
al	NULL
.	NULL

2000	NULL
.	NULL

Function	NULL
of	NULL
PBK	NULL
in	NULL
27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

53	NULL
.	NULL

54	NULL
.	NULL

3073	NULL
thymocyte	NULL
development	NULL
,	NULL
T	NULL
cell	NULL
activation	NULL
,	NULL
and	NULL
neutrophil	NULL
migration	NULL
.	NULL

Science	NULL
287	NULL
:	NULL
1040	NULL
.	NULL

Sotsios	NULL
,	NULL
Y.	NULL
,	NULL
G.	NULL
C.	NULL
Whittaker	NULL
,	NULL
J.	NULL
Westwick	NULL
,	NULL
and	NULL
S.	NULL
G.	NULL
Ward	NULL
.	NULL

1999	NULL
.	NULL

The	NULL
CXC	NULL
chemokine	NULL
stromal	NULL
cell-derived	NULL
factor	NULL
activates	NULL
a	NULL
Gi-coupled	NULL
phosphoinositide	NULL
3-kinase	NULL
in	NULL
T	NULL
lymphocytes	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

163:5954	NULL
.	NULL

Christopherson	NULL
,	NULL
K.	NULL
S.	NULL
,	NULL
and	NULL
D.	NULL
S.	NULL
Bredt	NULL
.	NULL

1997	NULL
.	NULL

Nitric	NULL
oxide	NULL
in	NULL
excitable	NULL
tissues	NULL
:	NULL
physiological	NULL
roles	NULL
and	NULL
disease	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

100:2424	NULL
.	NULL

Papapetropoulos	NULL
,	NULL
A.	NULL
,	NULL
G.	NULL
Garcia-Cardena	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Madri	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Sessa	NULL
.	NULL

1997	NULL
.	NULL

Nitric	NULL
oxide	NULL
production	NULL
contributes	NULL
to	NULL
the	NULL
angiogenic	NULL
properties	NULL
of	NULL
vascular	NULL
endothelial	NULL
growth	NULL
factor	NULL
in	NULL
human	NULL
endothelial	NULL
cells	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

100:3131	NULL
.	NULL

Geller	NULL
,	NULL
D.	NULL
A.	NULL
,	NULL
and	NULL
T.	NULL
R.	NULL
Billar	NULL
.	NULL

1998	NULL
.	NULL

Molecular	NULL
biology	NULL
of	NULL
nitric	NULL
oxide	NULL
synthases	NULL
.	NULL

Cancer	NULL
Metastasis	NULL
Rev	NULL
.	NULL

17:7	NULL
.	NULL

Lipton	NULL
,	NULL
S.	NULL
A	NULL
.	NULL

1999	NULL
.	NULL

Neuronal	NULL
protection	NULL
and	NULL
destruction	NULL
by	NULL
NO	NULL
.	NULL

Cell	NULL
Death	NULL
Differ	NULL
.	NULL

6:943	NULL
.	NULL

Williams	NULL
,	NULL
M.	NULL
S.	NULL
,	NULL
S.	NULL
Noguchi	NULL
,	NULL
P.	NULL
A.	NULL
Henkart	NULL
,	NULL
and	NULL
Y.	NULL
Osawa	NULL
.	NULL

1998	NULL
.	NULL

Nitric	NULL
oxide	NULL
synthase	NULL
plays	NULL
a	NULL
signaling	NULL
role	NULL
in	NULL
TCR-triggered	NULL
apoptotic	NULL
death	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

161:6526	NULL
.	NULL

Mannick	NULL
,	NULL
J	NULL
.	NULL

B.	NULL
,	NULL
X.	NULL
Q.	NULL
Miao	NULL
,	NULL
and	NULL
J.	NULL
S.	NULL
Stamler	NULL
.	NULL

1997	NULL
.	NULL

Nitric	NULL
oxide	NULL
inhibits	NULL
Fas-induced	NULL
apoptosis	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

272:24125	NULL
.	NULL

Sciorati	NULL
,	NULL
C.	NULL
,	NULL
P.	NULL
Rovere	NULL
,	NULL
M.	NULL
Ferrarini	NULL
,	NULL
S.	NULL
Heltai	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
Manfredi	NULL
,	NULL
and	NULL
E.	NULL
Clementi	NULL
.	NULL

1997	NULL
.	NULL

Autocrine	NULL
nitric	NULL
oxide	NULL
modulates	NULL
CD95-induced	NULL
apoptosis	NULL
in	NULL
48	NULL
T	NULL
lymphocytes	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

272:23211	NULL
.	NULL

Amin	NULL
,	NULL
A.	NULL
R.	NULL
,	NULL
M.	NULL
Attur	NULL
,	NULL
P.	NULL
Vyas	NULL
,	NULL
J.	NULL
Leszczynska-Piziak	NULL
,	NULL
D.	NULL
Levartovsky	NULL
,	NULL
J.	NULL
Rediske	NULL
,	NULL
R.	NULL
M.	NULL
Clancy	NULL
,	NULL
K.	NULL
A.	NULL
Vora	NULL
,	NULL
and	NULL
S.	NULL
B.	NULL
Abramson	NULL
.	NULL

1995	NULL
.	NULL

Expression	NULL
of	NULL
nitric	NULL
oxide	NULL
synthase	NULL
in	NULL
human	NULL
peripheral	NULL
blood	NULL
mononuclear	NULL
cells	NULL
and	NULL
neutrophils	NULL
.	NULL

J.	NULL
Inflamm	NULL
.	NULL

47:190	NULL
.	NULL

Mori	NULL
,	NULL
N.	NULL
,	NULL
Y.	NULL
Nunokawa	NULL
,	NULL
Y.	NULL
Yamada	NULL
,	NULL
S.	NULL
Ikeda	NULL
,	NULL
M.	NULL
Tomonaga	NULL
,	NULL
and	NULL
N.	NULL
Yamamoto	NULL
.	NULL

1999	NULL
.	NULL

Expression	NULL
of	NULL
human	NULL
inducible	NULL
nitric	NULL
oxide	NULL
synthase	NULL
gene	NULL
in	NULL
T-cell	NULL
lines	NULL
infected	NULL
with	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type-I	NULL
and	NULL
primary	NULL
adult	NULL
T-cell	NULL
leukemia	NULL
cells	NULL
.	NULL

Blood	NULL
94:2862	NULL
.	NULL

Fulton	NULL
,	NULL
D.	NULL
,	NULL
J.	NULL
P.	NULL
Gratton	NULL
,	NULL
T.	NULL
J.	NULL
McCabe	NULL
,	NULL
J.	NULL
Fontana	NULL
,	NULL
Y.	NULL
Fujio	NULL
,	NULL
K.	NULL
Walsh	NULL
,	NULL
T.	NULL
F.	NULL
Franke	NULL
,	NULL
A.	NULL
Papapetropoulos	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Sessa	NULL
.	NULL

1999	NULL
.	NULL

Regulation	NULL
of	NULL
endothelium-derived	NULL
nitric	NULL
oxide	NULL
production	NULL
by	NULL
the	NULL
protein	NULL
kinase	NULL
Akt	NULL
.	NULL

Nature	NULL
399:597	NULL
.	NULL

Michell	NULL
,	NULL
B.	NULL
J.	NULL
,	NULL
J.	NULL
E.	NULL
Griffiths	NULL
,	NULL
K.	NULL
I.	NULL
Mitchelhill	NULL
,	NULL
I.	NULL
Rodriguez-Crespo	NULL
,	NULL
T.	NULL
Tiganis	NULL
,	NULL
S.	NULL
Bozinovski	NULL
,	NULL
P.	NULL
R.	NULL
de	NULL
Montellano	NULL
,	NULL
B.	NULL
E.	NULL
Kemp	NULL
,	NULL
and	NULL
R.	NULL
B.	NULL
Pearson	NULL
.	NULL

1999	NULL
.	NULL

The	NULL
Akt	NULL
kinase	NULL
signals	NULL
directly	NULL
to	NULL
endothelial	NULL
nitric	NULL
oxide	NULL
synthase	NULL
.	NULL

Curr	NULL
.	NULL

Biol	NULL
.	NULL

9:845	NULL
.	NULL

Dimmeler	NULL
,	NULL
S.	NULL
,	NULL
L	NULL
Fleming	NULL
,	NULL
B.	NULL
Fisslthaler	NULL
,	NULL
C.	NULL
Hermann	NULL
,	NULL
R.	NULL
Busse	NULL
,	NULL
and	NULL
A.	NULL
M.	NULL
Zciher	NULL
.	NULL

1999	NULL
.	NULL

Activation	NULL
of	NULL
nitric	NULL
oxide	NULL
synthase	NULL
in	NULL
endothelial	NULL
cells	NULL
by	NULL
Akt-dependent	NULL
phosphorylation	NULL
.	NULL

Nature	NULL
399:601	NULL
.	NULL

Sacki	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
S.	NULL
Maeda	NULL
.	NULL

1999.	NULL
p13O0cas	NULL
is	NULL
a	NULL
cellular	NULL
target	NULL
protein	NULL
for	NULL
tyrosine	NULL
nitration	NULL
induced	NULL
by	NULL
peroxynitrite	NULL
.	NULL

Neurosci	NULL
.	NULL

Res	NULL
.	NULL

33:325	NULL
.	NULL

Baldwin	NULL
,	NULL
A.	NULL
S.	NULL
,	NULL
Jr.	NULL
1996	NULL
.	NULL

The	NULL
NF-KB	NULL
and	NULL
IxB	NULL
proteins	NULL
:	NULL
new	NULL
discoveries	NULL
and	NULL
insights	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

14:649	NULL
.	NULL

Kleinert	NULL
,	NULL
H.	NULL
,	NULL
C.	NULL
Euchenhofer	NULL
,	NULL
I.	NULL
Thrig-Biedert	NULL
,	NULL
and	NULL
U.	NULL
Porstermann	NULL
.	NULL

1996	NULL
.	NULL

In	NULL
murine	NULL
3T3	NULL
fibroblasts	NULL
,	NULL
different	NULL
second	NULL
messenger	NULL
pathways	NULL
resulting	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
NO	NULL
synthase	NULL
II	NULL
(	NULL
iNOS	NULL
)	NULL
converge	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
transcription	NULL
factor	NULL
NF-kB	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271:6039	NULL
.	NULL

Zhang	NULL
,	NULL
J.	NULL
,	NULL
L.	NULL
W.	NULL
Velsor	NULL
,	NULL
J.	NULL
M.	NULL
Patel	NULL
,	NULL
E.	NULL
M.	NULL
Postlethwait	NULL
,	NULL
and	NULL
E.	NULL
R.	NULL
Block	NULL
.	NULL

1999	NULL
.	NULL

Nitric	NULL
oxide-induced	NULL
reduction	NULL
of	NULL
Tung	NULL
cell	NULL
and	NULL
whole	NULL
lung	NULL
thioredoxin	NULL
expression	NULL
is	NULL
regulated	NULL
by	NULL
NF-kB	NULL
.	NULL

Am	NULL
.	NULL

J.	NULL
Physiol	NULL
.	NULL

277	NULL
:	NULL
L787	NULL
.	NULL

.	NULL

Umansky	NULL
,	NULL
V.	NULL
,	NULL
S.	NULL
P.	NULL
Hehner	NULL
,	NULL
A.	NULL
Dumont	NULL
,	NULL
T.	NULL
G.	NULL
Hofmann	NULL
,	NULL
V.	NULL
Schirrmacher	NULL
,	NULL
W.	NULL
Droge	NULL
,	NULL
and	NULL
M.	NULL
L.	NULL
Schmitz	NULL
.	NULL

1998	NULL
.	NULL

Co-stimulatory	NULL
effect	NULL
of	NULL
nitric	NULL
oxide	NULL
on	NULL
endothelial	NULL
NF-kB	NULL
implies	NULL
a	NULL
physiological	NULL
self-amplifying	NULL
mechanism	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

28:2276	NULL
.	NULL

Beauvais	NULL
,	NULL
F.	NULL
,	NULL
L.	NULL
Michel	NULL
,	NULL
and	NULL
L.	NULL
Dubertret	NULL
.	NULL

1995	NULL
.	NULL

Exogenous	NULL
nitric	NULL
oxide	NULL
elicits	NULL
chemotaxis	NULL
of	NULL
neutrophils	NULL
in	NULL
vitro	NULL
.	NULL

J	NULL
.	NULL

Cell	NULL
Physiol	NULL
.	NULL

165:610	NULL
.	NULL

Murohara	NULL
,	NULL
T.	NULL
,	NULL
B.	NULL
Witzenbichler	NULL
,	NULL
I.	NULL
Spyridopoulos	NULL
,	NULL
T.	NULL
Asahara	NULL
,	NULL
B.	NULL
Ding	NULL
,	NULL
A.	NULL
Sullivan	NULL
,	NULL
D.	NULL
W.	NULL
Losordo	NULL
,	NULL
and	NULL
J.	NULL
M.	NULL
Isner	NULL
.	NULL

1999	NULL
.	NULL

Role	NULL
of	NULL
endothelial	NULL
nitric	NULL
oxide	NULL
synthase	NULL
in	NULL
endothelial	NULL
cell	NULL
migration	NULL
.	NULL

Arterioscler	NULL
.	NULL

Thromb	NULL
.	NULL

Vasc	NULL
.	NULL

Biol	NULL
.	NULL

19:1156	NULL
.	NULL

Sarkar	NULL
,	NULL
R.	NULL
,	NULL
E.	NULL
G.	NULL
Meinberg	NULL
,	NULL
J.	NULL
C.	NULL
Stanley	NULL
,	NULL
D.	NULL
Gordon	NULL
,	NULL
and	NULL
R.	NULL
C.	NULL
Webb	NULL
.	NULL

1996	NULL
.	NULL

Nitric	NULL
oxide	NULL
reversibly	NULL
inhibits	NULL
the	NULL
migration	NULL
of	NULL
cultured	NULL
vascular	NULL
smooth	NULL
muscle	NULL
cells	NULL
.	NULL

Cire	NULL
.	NULL

Res	NULL
.	NULL

78:225	NULL
.	NULL

Noiri	NULL
,	NULL
E.	NULL
,	NULL
Y.	NULL
Hu	NULL
,	NULL
W.	NULL
F.	NULL
Bahou	NULL
,	NULL
C.	NULL
R.	NULL
Keese	NULL
,	NULL
I.	NULL
Giaever	NULL
,	NULL
and	NULL
M.	NULL
S.	NULL
Goligorsky	NULL
.	NULL

1997	NULL
.	NULL

Permissive	NULL
role	NULL
of	NULL
nitric	NULL
oxide	NULL
in	NULL
endothelin-induced	NULL
migration	NULL
of	NULL
endothelial	NULL
cells	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

272:1747	NULL
.	NULL

Ganju	NULL
,	NULL
R.	NULL
K.	NULL
,	NULL
P.	NULL
Dutt	NULL
,	NULL
L.	NULL
Wu	NULL
,	NULL
W.	NULL
Newman	NULL
,	NULL
H.	NULL
Avraham	NULL
,	NULL
S.	NULL
Avraham	NULL
,	NULL
and	NULL
J.	NULL
E.	NULL
Groopman	NULL
.	NULL

1998	NULL
.	NULL

6-Chemokine	NULL
receptor	NULL
CCRS	NULL
signals	NULL
via	NULL
the	NULL
novel	NULL
tyrosine	NULL
kinase	NULL
RAFTK	NULL
.	NULL

Blood	NULL
91:791	NULL
.	NULL

Ganju	NULL
,	NULL
R.	NULL
K.	NULL
,	NULL
W.	NULL
C.	NULL
Hatch	NULL
,	NULL
H.	NULL
Avraham	NULL
,	NULL
M.	NULL
A.	NULL
Ona	NULL
,	NULL
B.	NULL
Druker	NULL
,	NULL
S.	NULL
Avraham	NULL
,	NULL
and	NULL
J.	NULL
E.	NULL
Groopman	NULL
.	NULL

1997	NULL
.	NULL

RAFTK	NULL
,	NULL
a	NULL
novel	NULL
member	NULL
of	NULL
the	NULL
focal	NULL
adhesion	NULL
kinase	NULL
family	NULL
,	NULL
is	NULL
phosphorylated	NULL
and	NULL
associates	NULL
with	NULL
signaling	NULL
molecules	NULL
upon	NULL
activation	NULL
of	NULL
mature	NULL
T	NULL
lymphocytes	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

185:1055	NULL
.	NULL

Griscavage	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
S.	NULL
Wilk	NULL
,	NULL
and	NULL
L.	NULL
J.	NULL
Ignarro	NULL
.	NULL

1995	NULL
.	NULL

Serine	NULL
and	NULL
cysteine	NULL
proteinase	NULL
inhibitors	NULL
prevent	NULL
nitric	NULL
oxide	NULL
production	NULL
by	NULL
activated	NULL
macrophages	NULL
by	NULL
interfering	NULL
with	NULL
transcription	NULL
of	NULL
the	NULL
inducible	NULL
NO	NULL
synthase	NULL
gene	NULL
.	NULL

Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Res	NULL
.	NULL

Commun	NULL
.	NULL

215:721	NULL
.	NULL

Hattori	NULL
,	NULL
Y.	NULL
,	NULL
N.	NULL
Nakanishi	NULL
,	NULL
and	NULL
K.	NULL
Kasai	NULL
.	NULL

1997	NULL
.	NULL

Role	NULL
of	NULL
nuclear	NULL
factor	NULL
xB	NULL
in	NULL
cytokine-induced	NULL
nitric	NULL
oxide	NULL
and	NULL
tetrahydrobiopterin	NULL
synthesis	NULL
in	NULL
rat	NULL
neonatal	NULL
cardiac	NULL
myo-cytes	NULL
.	NULL

J.	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Cardiol	NULL
.	NULL

29:1585	NULL
.	NULL

Kwon	NULL
,	NULL
G.	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Corbett	NULL
,	NULL
S.	NULL
Hauser	NULL
,	NULL
J.	NULL
R.	NULL
Hill	NULL
,	NULL
J.	NULL
Turk	NULL
,	NULL
and	NULL
M.	NULL
L.	NULL
McDaniel	NULL
.	NULL

1998	NULL
.	NULL

Evidence	NULL
for	NULL
involvement	NULL
of	NULL
the	NULL
proteasome	NULL
complex	NULL
(	NULL
268	NULL
)	NULL
and	NULL
NFkB	NULL
in	NULL
induced	NULL
nitric	NULL
oxide	NULL
and	NULL
prostaglandin	NULL
production	NULL
by	NULL
rat	NULL
islets	NULL
and	NULL
RINmSF	NULL
cells	NULL
.	NULL

Diabetes	NULL
47:583	NULL
.	NULL

Lin	NULL
,	NULL
Y	NULL
.	NULL

Z.	NULL
,	NULL
S.	NULL
Y.	NULL
Yao	NULL
,	NULL
R.	NULL
A.	NULL
Veach	NULL
,	NULL
T.	NULL
R.	NULL
Torgerson	NULL
,	NULL
and	NULL
J.	NULL
Hawiger	NULL
.	NULL

1995	NULL
.	NULL

Inhibition	NULL
of	NULL
nuclear	NULL
translocation	NULL
of	NULL
transcription	NULL
factor	NULL
NF-KB	NULL
by	NULL
a	NULL
synthetic	NULL
peptide	NULL
containing	NULL
a	NULL
cell	NULL
membrane-permeable	NULL
motif	NULL
and	NULL
nuclear	NULL
localization	NULL
sequence	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270:14255	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
3074	NULL
55	NULL
.	NULL

56	NULL
.	NULL

57	NULL
.	NULL

58	NULL
.	NULL

59	NULL
.	NULL

60	NULL
.	NULL

61	NULL
.	NULL

62	NULL
.	NULL

63	NULL
.	NULL

65	NULL
.	NULL

66	NULL
.	NULL

67	NULL
.	NULL

68	NULL
.	NULL

69	NULL
.	NULL

Jo	NULL
,	NULL
D.	NULL
Y.	NULL
,	NULL
S.	NULL
Rafii	NULL
,	NULL
T.	NULL
Hamada	NULL
,	NULL
and	NULL
M.	NULL
A.	NULL
Moore	NULL
.	NULL

2000	NULL
.	NULL

Chemotaxis	NULL
of	NULL
primitive	NULL
hematopoietic	NULL
cells	NULL
in	NULL
response	NULL
to	NULL
stromal	NULL
cell-	NULL
derived	NULL
factor-1	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

105	NULL
:	NULL
101	NULL
.	NULL

Rempel	NULL
,	NULL
S.	NULL
A.	NULL
,	NULL
S.	NULL
Dudas	NULL
,	NULL
S.	NULL
Ge	NULL
,	NULL
and	NULL
J	NULL
.	NULL

A.	NULL
Gutierrez	NULL
.	NULL

2000	NULL
.	NULL

Identification	NULL
and	NULL
localization	NULL
of	NULL
the	NULL
cytokine	NULL
SDF1	NULL
and	NULL
its	NULL
receptor	NULL
,	NULL
CXC	NULL
chemokine	NULL
receptor	NULL
4	NULL
,	NULL
to	NULL
regions	NULL
of	NULL
necrosis	NULL
and	NULL
angiogenesis	NULL
in	NULL
human	NULL
glioblastoma	NULL
.	NULL

Clin	NULL
.	NULL

Cancer	NULL
Res	NULL
.	NULL

6:102	NULL
.	NULL

Lataillade	NULL
,	NULL
J.	NULL
J.	NULL
,	NULL
D.	NULL
Clay	NULL
,	NULL
C.	NULL
Dupuy	NULL
,	NULL
S.	NULL
Rigal	NULL
,	NULL
C.	NULL
Jasmin	NULL
,	NULL
P.	NULL
Bourin	NULL
,	NULL
and	NULL
M.	NULL
C.	NULL
Le	NULL
Bousse-Kerdiles	NULL
.	NULL

2000	NULL
.	NULL

Chemokine	NULL
SDF-1	NULL
enhances	NULL
circulating	NULL
CD34	NULL
*	NULL
cell	NULL
proliferation	NULL
in	NULL
synergy	NULL
with	NULL
cytokines	NULL
:	NULL
possible	NULL
role	NULL
in	NULL
progenitor	NULL
survival	NULL
.	NULL

Blood	NULL
95:756	NULL
.	NULL

Vila-Coro	NULL
,	NULL
A.	NULL
J.	NULL
,	NULL
J.	NULL
M.	NULL
Rodriguez-Frade	NULL
,	NULL
A.	NULL
Martin	NULL
De	NULL
Ana	NULL
,	NULL
M.	NULL
C.	NULL
Moreno-Ortiz	NULL
,	NULL
A.	NULL
C.	NULL
Martinez	NULL
,	NULL
and	NULL
M.	NULL
Mellado	NULL
.	NULL

1999	NULL
.	NULL

The	NULL
chemokine	NULL
SDF-1alpha	NULL
triggers	NULL
CXCR4	NULL
receptor	NULL
dimerization	NULL
and	NULL
activates	NULL
the	NULL
JAK/STAT	NULL
pathway	NULL
.	NULL

FASEB	NULL
J	NULL
.	NULL

13:1699	NULL
.	NULL

Shen	NULL
,	NULL
B.	NULL
Q.	NULL
,	NULL
D.	NULL
Y.	NULL
Lee	NULL
,	NULL
and	NULL
T.	NULL
F.	NULL
Zioncheck	NULL
.	NULL

1999	NULL
.	NULL

Vascular	NULL
endothelial	NULL
growth	NULL
factor	NULL
governs	NULL
endothelial	NULL
nitric-oxide	NULL
synthase	NULL
expression	NULL
via	NULL
a	NULL
KDR/Flk-1	NULL
receptor	NULL
and	NULL
a	NULL
protein	NULL
kinase	NULL
C	NULL
signaling	NULL
pathway	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

274:33057	NULL
.	NULL

Assreuy	NULL
,	NULL
J.	NULL
,	NULL
F.	NULL
Q.	NULL
Cunha	NULL
,	NULL
F.	NULL
Y.	NULL
Liew	NULL
,	NULL
and	NULL
S.	NULL
Moncada	NULL
.	NULL

1993	NULL
.	NULL

Feedback	NULL
inhibition	NULL
of	NULL
nitric	NULL
oxide	NULL
synthase	NULL
activity	NULL
by	NULL
nitric	NULL
oxide	NULL
.	NULL

Br	NULL
.	NULL

J.	NULL
Pharmacol	NULL
.	NULL

108:83	NULL
.	NULL

Noiri	NULL
,	NULL
E.	NULL
,	NULL
E.	NULL
Lee	NULL
,	NULL
J.	NULL
Testa	NULL
,	NULL
J.	NULL
Quigley	NULL
,	NULL
D.	NULL
Colflesh	NULL
,	NULL
C.	NULL
R.	NULL
Keese	NULL
,	NULL
I.	NULL
Giaever	NULL
,	NULL
and	NULL
M.	NULL
S.	NULL
Goligorsky	NULL
.	NULL

1998	NULL
.	NULL

Podokinesis	NULL
in	NULL
endothelial	NULL
cell	NULL
migration	NULL
:	NULL
role	NULL
of	NULL
nitric	NULL
oxide	NULL
.	NULL

Am	NULL
.	NULL

J.	NULL
Physiol	NULL
.	NULL

274	NULL
:	NULL
C236	NULL
.	NULL

Frenkel	NULL
,	NULL
S.	NULL
R.	NULL
,	NULL
R.	NULL
M.	NULL
Clancy	NULL
,	NULL
J.	NULL
L.	NULL
Ricci	NULL
,	NULL
P.	NULL
E.	NULL
Di	NULL
Cesare	NULL
,	NULL
J.	NULL
J.	NULL
Rediske	NULL
,	NULL
and	NULL
S.	NULL
B.	NULL
Abramson	NULL
.	NULL

1996	NULL
.	NULL

Effects	NULL
of	NULL
nitric	NULL
oxide	NULL
on	NULL
chondrocyte	NULL
migration	NULL
,	NULL
adhesion	NULL
,	NULL
and	NULL
cytoskeletal	NULL
assembly	NULL
.	NULL

Arthritis	NULL
Rheum	NULL
.	NULL

39:1905	NULL
.	NULL

Chen	NULL
,	NULL
A.	NULL
,	NULL
S.	NULL
M.	NULL
Kumar	NULL
,	NULL
C.	NULL
L.	NULL
Sahley	NULL
,	NULL
and	NULL
K.	NULL
J.	NULL
Muller	NULL
.	NULL

2000	NULL
.	NULL

Nitric	NULL
oxide	NULL
influences	NULL
injury-induced	NULL
microglial	NULL
migration	NULL
and	NULL
accumulation	NULL
in	NULL
the	NULL
leech	NULL
CNS	NULL
.	NULL

J.	NULL
Newrosci	NULL
.	NULL

20:1036.	NULL
.	NULL

Lau	NULL
,	NULL
Y.	NULL
T.	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Ma	NULL
.	NULL

1996	NULL
.	NULL

Nitric	NULL
oxide	NULL
inhibits	NULL
migration	NULL
of	NULL
cultured	NULL
endo-	NULL
thelial	NULL
cells	NULL
.	NULL

Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Res	NULL
.	NULL

Commun	NULL
.	NULL

221:670	NULL
.	NULL

Hokari	NULL
,	NULL
R.	NULL
,	NULL
S.	NULL
Miura	NULL
,	NULL
H.	NULL
Fujimori	NULL
,	NULL
Y.	NULL
Tsuzuki	NULL
,	NULL
T.	NULL
Shigematsu	NULL
,	NULL
H.	NULL
Higuchi	NULL
,	NULL
H.	NULL
Kimura	NULL
,	NULL
I.	NULL
Kurose	NULL
,	NULL
H.	NULL
Serizawa	NULL
,	NULL
M.	NULL
Suematsu	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1998	NULL
.	NULL

Nitric	NULL
oxide	NULL
modulates	NULL
T-lymphocyte	NULL
migration	NULL
in	NULL
Peyer	NULL
's	NULL
patches	NULL
and	NULL
villous	NULL
submucosa	NULL
of	NULL
rat	NULL
small	NULL
in-testine	NULL
.	NULL

Gastroenterology	NULL
115:618	NULL
.	NULL

Goligorsky	NULL
,	NULL
M.	NULL
S.	NULL
,	NULL
H.	NULL
Abedi	NULL
,	NULL
E.	NULL
Noiri	NULL
,	NULL
A.	NULL
Takhtajan	NULL
,	NULL
S.	NULL
Lense	NULL
,	NULL
V.	NULL
Romanov	NULL
,	NULL
and	NULL
I.	NULL
Zachary	NULL
.	NULL

1999	NULL
.	NULL

Nitric	NULL
oxide	NULL
modulation	NULL
of	NULL
focal	NULL
adhesions	NULL
in	NULL
endothelial	NULL
cells	NULL
.	NULL

Am	NULL
.	NULL

J.	NULL
Physiol	NULL
.	NULL

276	NULL
:	NULL
C1271	NULL
.	NULL

Clancy	NULL
,	NULL
R.	NULL
1999	NULL
.	NULL

Nitric	NULL
oxide	NULL
alters	NULL
chondrocyte	NULL
function	NULL
by	NULL
disrupting	NULL
cytoskeletal	NULL
signaling	NULL
complexes	NULL
.	NULL

Osteoarthritis	NULL
Cartilage	NULL
7:399	NULL
.	NULL

Katsuyama	NULL
,	NULL
K.	NULL
,	NULL
M.	NULL
Shichiri	NULL
,	NULL
F.	NULL
Marumo	NULL
,	NULL
and	NULL
Y.	NULL
Hirata	NULL
.	NULL

1998	NULL
.	NULL

Role	NULL
of	NULL
nuclear	NULL
fac-activation	NULL
in	NULL
cytokine-	NULL
and	NULL
sphingomyelinase-stimulated	NULL
inducible	NULL
nitric	NULL
oxide	NULL
synthase	NULL
gene	NULL
expression	NULL
in	NULL
vascular	NULL
smooth	NULL
muscle	NULL
cells	NULL
.	NULL

Endocrinology	NULL
139:4506	NULL
.	NULL

Marks-Konczalik	NULL
,	NULL
J.	NULL
,	NULL
S.	NULL
C.	NULL
Chu	NULL
,	NULL
and	NULL
J.	NULL
Moss	NULL
.	NULL

1998	NULL
.	NULL

Cytokine-mediated	NULL
transcriptional	NULL
induction	NULL
of	NULL
the	NULL
human	NULL
inducible	NULL
nitric	NULL
oxide	NULL
synthase	NULL
gene	NULL
requires	NULL
both	NULL
activator	NULL
protein	NULL
1	NULL
and	NULL
nuclear	NULL
factor	NULL
xB-binding	NULL
sites	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

273:22201	NULL
.	NULL

70	NULL
.	NULL

71	NULL
.	NULL

72	NULL
.	NULL

73	NULL
.	NULL

74	NULL
.	NULL

75	NULL
.	NULL

76	NULL
.	NULL

77	NULL
.	NULL

78	NULL
.	NULL

79	NULL
.	NULL

80	NULL
.	NULL

81	NULL
.	NULL

82	NULL
.	NULL

83	NULL
.	NULL

NO	NULL
MEDIATES	NULL
SDFia	NULL
@	NULL
-INDUCED	NULL
CHEMOTAXIS	NULL
Benoliel	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
B.	NULL
Kahn-Peries	NULL
,	NULL
J.	NULL
Imbert	NULL
,	NULL
and	NULL
P.	NULL
Verrando	NULL
.	NULL

1997	NULL
.	NULL

Insulin	NULL
stimulates	NULL
haptotactic	NULL
migration	NULL
of	NULL
human	NULL
epidermal	NULL
keratinocytes	NULL
through	NULL
activation	NULL
of	NULL
NF-kB	NULL
transcription	NULL
factor	NULL
.	NULL

J	NULL
.	NULL

Cell	NULL
Sci	NULL
.	NULL

110:2089	NULL
.	NULL

Ikebe	NULL
,	NULL
T.	NULL
,	NULL
H.	NULL
Takeuchi	NULL
,	NULL
E.	NULL
Jimi	NULL
,	NULL
M.	NULL
Beppu	NULL
,	NULL
M.	NULL
Shinohara	NULL
,	NULL
and	NULL
K.	NULL
Shirasuna	NULL
.	NULL

1998	NULL
.	NULL

Involvement	NULL
of	NULL
proteasomes	NULL
in	NULL
migration	NULL
and	NULL
matrix	NULL
metalloproteinase-9	NULL
production	NULL
of	NULL
oral	NULL
squamous	NULL
cell	NULL
carcinoma	NULL
.	NULL

Int	NULL
.	NULL

J	NULL
.	NULL

Cancer	NULL
77:578	NULL
.	NULL

Yebra	NULL
,	NULL
M.	NULL
,	NULL
E.	NULL
J.	NULL
Filardo	NULL
,	NULL
E.	NULL
M.	NULL
Bayna	NULL
,	NULL
E.	NULL
Kawahara	NULL
,	NULL
J.	NULL
C.	NULL
Becker	NULL
,	NULL
and	NULL
D.	NULL
A.	NULL
Cheresh	NULL
.	NULL

1995	NULL
.	NULL

Induction	NULL
of	NULL
carcinoma	NULL
cell	NULL
migration	NULL
on	NULL
vitronectin	NULL
by	NULL
NF-kB-dependent	NULL
gene	NULL
expression	NULL
.	NULL

Mol	NULL
.	NULL

Biol	NULL
.	NULL

Cell	NULL
.	NULL

6:841	NULL
.	NULL

Romashkova	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
and	NULL
S.	NULL
S.	NULL
Makarov	NULL
.	NULL

1999	NULL
.	NULL

NF-KB	NULL
is	NULL
a	NULL
target	NULL
of	NULL
AKT	NULL
in	NULL
anti-apoptotic	NULL
PDGF	NULL
signalling	NULL
.	NULL

Nature	NULL
401:86	NULL
.	NULL

Ozes	NULL
,	NULL
O.	NULL
N.	NULL
,	NULL
L.	NULL
D.	NULL
Mayo	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Gustin	NULL
,	NULL
S.	NULL
R.	NULL
Pfeffer	NULL
,	NULL
L.	NULL
M.	NULL
Pfeffer	NULL
,	NULL
and	NULL
D.	NULL
B.	NULL
Donner	NULL
.	NULL

1999	NULL
.	NULL

NF-B	NULL
activation	NULL
by	NULL
tumour	NULL
necrosis	NULL
factor	NULL
requires	NULL
the	NULL
Akt	NULL
serine-threonine	NULL
kinase	NULL
.	NULL

Nature	NULL
401:82	NULL
.	NULL

Wang	NULL
,	NULL
J.	NULL
F.	NULL
,	NULL
I	NULL
W.	NULL
Park	NULL
,	NULL
and	NULL
J.	NULL
E.	NULL
Groopman	NULL
.	NULL

2000	NULL
.	NULL

Stromal	NULL
cell	NULL
derived	NULL
factor	NULL
-14	NULL
stimulates	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
multiple	NULL
focal	NULL
adhesion	NULL
proteins	NULL
and	NULL
induces	NULL
migration	NULL
of	NULL
hematopoietic	NULL
progenitor	NULL
cells	NULL
:	NULL
roles	NULL
of	NULL
phosphoinositide-3	NULL
kinase	NULL
and	NULL
protein	NULL
kinase	NULL
C.	NULL
Blood	NULL
95:2505	NULL
.	NULL

Cheresh	NULL
,	NULL
D.	NULL
A.	NULL
,	NULL
J.	NULL
Leng	NULL
,	NULL
and	NULL
R.	NULL
L.	NULL
Klemke	NULL
.	NULL

1999	NULL
.	NULL

Regulation	NULL
of	NULL
cell	NULL
contraction	NULL
and	NULL
membrane	NULL
ruffling	NULL
by	NULL
distinct	NULL
signals	NULL
in	NULL
migratory	NULL
cells	NULL
.	NULL

J	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

146:1107	NULL
.	NULL

Jeon	NULL
,	NULL
Y.	NULL
J.	NULL
,	NULL
Y.	NULL
K.	NULL
Kim	NULL
,	NULL
M.	NULL
Lee	NULL
,	NULL
S.	NULL
M.	NULL
Park	NULL
,	NULL
S.	NULL
B.	NULL
Han	NULL
,	NULL
and	NULL
H.	NULL
M.	NULL
Kim	NULL
.	NULL

2000	NULL
.	NULL

Radicicol	NULL
suppresses	NULL
expression	NULL
of	NULL
inducible	NULL
nitric-oxide	NULL
synthase	NULL
by	NULL
blocking	NULL
p38	NULL
kinase	NULL
and	NULL
nuclear	NULL
factor-KB/Rel	NULL
in	NULL
lipopolysaccharide-stimulated	NULL
macrophages	NULL
.	NULL

J.	NULL
Pharmacol	NULL
.	NULL

Exp	NULL
.	NULL

Ther	NULL
.	NULL

294:548	NULL
.	NULL

Paul	NULL
,	NULL
A.	NULL
,	NULL
A.	NULL
Cuenda	NULL
,	NULL
C.	NULL
E.	NULL
Bryant	NULL
,	NULL
J.	NULL
Murray	NULL
,	NULL
E.	NULL
R.	NULL
Chilvers	NULL
,	NULL
P.	NULL
Cohen	NULL
,	NULL
G.	NULL
W.	NULL
Gould	NULL
,	NULL
and	NULL
R.	NULL
Plevin	NULL
.	NULL

1999	NULL
.	NULL

Involvement	NULL
of	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
homologues	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
lipopolysaccharide-mediated	NULL
induction	NULL
of	NULL
cyclo-oxygenase-2	NULL
but	NULL
not	NULL
nitric	NULL
oxide	NULL
synthase	NULL
in	NULL
RAW	NULL
264.7	NULL
macrophages	NULL
.	NULL

Cell	NULL
.	NULL

Signal	NULL
.	NULL

11:491	NULL
.	NULL

Parenti	NULL
,	NULL
A.	NULL
,	NULL
L.	NULL
Morbidelli	NULL
,	NULL
X.	NULL
L.	NULL
Cui	NULL
,	NULL
J.	NULL
G.	NULL
Douglas	NULL
,	NULL
J.	NULL
D.	NULL
Hood	NULL
,	NULL
H.	NULL
J.	NULL
Granger	NULL
,	NULL
F.	NULL
Ledda	NULL
,	NULL
and	NULL
M.	NULL
Ziche	NULL
.	NULL

1998	NULL
.	NULL

Nitric	NULL
oxide	NULL
is	NULL
an	NULL
upstream	NULL
signal	NULL
of	NULL
vascular	NULL
endothelial	NULL
growth	NULL
factor-induced	NULL
extracellular	NULL
signal-regulated	NULL
kinasel/2	NULL
activation	NULL
in	NULL
postcapillary	NULL
endothelium	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

273:4220	NULL
.	NULL

Chiu	NULL
,	NULL
J.	NULL
J.	NULL
,	NULL
B.	NULL
S.	NULL
Wung	NULL
,	NULL
H.	NULL
J.	NULL
Hsich	NULL
,	NULL
L.	NULL
W.	NULL
Lo	NULL
,	NULL
and	NULL
D.	NULL
L.	NULL
Wang	NULL
.	NULL

1999	NULL
.	NULL

Nitric	NULL
oxide	NULL
regulates	NULL
shear	NULL
stress-induced	NULL
early	NULL
growth	NULL
response-1	NULL
:	NULL
expression	NULL
via	NULL
the	NULL
extracellular	NULL
signal-regulated	NULL
kinase	NULL
pathway	NULL
in	NULL
endothelial	NULL
cells	NULL
.	NULL

Circ	NULL
.	NULL

Res	NULL
.	NULL

85:238	NULL
.	NULL

Komalavilas	NULL
,	NULL
P.	NULL
,	NULL
P.	NULL
K.	NULL
Shah	NULL
,	NULL
H.	NULL
Jo	NULL
,	NULL
and	NULL
T.	NULL
M.	NULL
Lincoln	NULL
.	NULL

1999	NULL
.	NULL

Activation	NULL
of	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
pathways	NULL
by	NULL
cyclic	NULL
GMP	NULL
and	NULL
cyclic	NULL
GMP	NULL
-dependent	NULL
protein	NULL
kinase	NULL
in	NULL
contractile	NULL
vascular	NULL
smooth	NULL
muscle	NULL
cells	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

274:34301	NULL
.	NULL

Lahti	NULL
,	NULL
A.	NULL
,	NULL
M.	NULL
Lahde	NULL
,	NULL
H.	NULL
Kankaanranta	NULL
,	NULL
and	NULL
E.	NULL
Moilanen	NULL
.	NULL

2000	NULL
.	NULL

Inhibition	NULL
of	NULL
extracellular	NULL
signal-regulated	NULL
kinase	NULL
suppresses	NULL
endotoxin-induced	NULL
nitric	NULL
oxide	NULL
synthesis	NULL
in	NULL
mouse	NULL
macrophages	NULL
and	NULL
in	NULL
human	NULL
colon	NULL
epithelial	NULL
cells	NULL
.	NULL

J.	NULL
Pharmacol	NULL
.	NULL

Exp	NULL
.	NULL

Ther	NULL
.	NULL

294:1188	NULL
.	NULL

Jiang	NULL
,	NULL
B.	NULL
,	NULL
and	NULL
P.	NULL
Brecher	NULL
.	NULL

2000	NULL
.	NULL

N-acetyl-L-cysteine	NULL
potentiates	NULL
interleukin-1	NULL
induction	NULL
of	NULL
nitric	NULL
oxide	NULL
synthase	NULL
:	NULL
role	NULL
of	NULL
p44/42	NULL
mitogen-activated	NULL
protein	NULL
kinases	NULL
.	NULL

Hypertension	NULL
35:914	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL

